The in vitro generation of effector lymphocytes and their employment in tumor immunotherapy.

[1]  J. Zerrahn,et al.  Natural Killer Cells , 2010 .

[2]  J. Mossin,et al.  Typing by cytotoxic lymphocytes. Genetics of HLA-non-A, B, C determinants - family studies. , 2008, Tissue antigens.

[3]  A. Bøyum,et al.  Separation of blood leucocytes, granulocytes and lymphocytes. , 2008, Tissue antigens.

[4]  N. Grunnet,et al.  Cell mediated lympholysis in man. Occurrence of unexpected, HL-A (LA and FOUR) irrelevant lympholysis. , 2008, Tissue antigens.

[5]  A. Goldstein,et al.  The Potential role of T cells in cancer therapy , 1984 .

[6]  H. Schellekens,et al.  Phytohaemagglutinin-induced susceptibility to lysis by natural and activated killer cells of autologous allogeneic and xenogeneic target cells. , 1982, Molecular immunology.

[7]  E. Klein,et al.  Expression of H-2b alloantigens in a variant of a Moloney virus-induced YAC (H-2a) lymphoma. , 1982, European journal of cancer & clinical oncology.

[8]  B. Vose,et al.  Quantitation of proliferative and cytotoxic precursor cells directed against human tumours: Limiting dilution analysis in peripheral blood and at the tumour site , 1982, International journal of cancer.

[9]  R. Germain,et al.  Role of syngeneic Ia+ accessory cells in the generation of allospecific CTL responses. , 1982, Journal of immunology.

[10]  T. Eberlein,et al.  Regression of a disseminated syngeneic solid tumor by systemic transfer of lymphoid cells expanded in interleukin 2. , 1982, The Journal of experimental medicine.

[11]  S. Rosenberg,et al.  In vitro growth of cytotoxic human lymphocytes. V. Generation of allospecific cytotoxic lymphocytes to nonimmunogenic antigen by supplementation of in vitro sensitization with partially purified T-cell growth factor. , 1982, Cellular immunology.

[12]  S. Rosenberg,et al.  Immunotherapy of Human Cancer , 1982 .

[13]  S. Rosenberg,et al.  Lymphokine-activated killer cell phenomenon. Lysis of natural killer- resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes , 1982, The Journal of experimental medicine.

[14]  S. Efrat,et al.  Kinetics of induction and molecular size of mRNAs encoding human interleukin-2 and γ-interferon , 1982, Nature.

[15]  E. Klein,et al.  Specificity of auto‐tumor cytotoxicity exerted by fresh, activated and propagated human t lymphocytes , 1982, International journal of cancer.

[16]  B. Bonavida,et al.  Propagation of mouse cytotoxic clones with characteristics of natural killer (NK) cells. , 1982, Cellular immunology.

[17]  E. Yefenof,et al.  Nonimmunogenic radiation-induced lymphoma: immunity induction by a somatic cell hybrid. , 1982, Journal of the National Cancer Institute.

[18]  C. Henney,et al.  Characterization of five cloned murine cell lines showing high cytolytic activity against YAC-1 cells. , 1982, Journal of immunology.

[19]  S. Herrmann,et al.  Analysis of the two-signal requirement for precursor cytolytic T lymphocyte activation using H-2Kk in liposomes. , 1982, Journal of immunology.

[20]  M. Bevan,et al.  A differentiation factor required for the expression of cytotoxic T-cell function , 1982, Nature.

[21]  J. Watson,et al.  Molecular Characterization of Interleukin 2 , 1982, Federation proceedings.

[22]  J. Strominger,et al.  Long-term human cytolytic T-cell lines allospecific for HLA-DR6 antigen are OKT4+. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[23]  P. Greenberg,et al.  Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2 , 1982, The Journal of experimental medicine.

[24]  P. Wernet,et al.  Long-term culture, cloning, and surface markers of mixed leukocyte culture-derived human T lymphocytes with natural killer-like cytotoxicity. , 1982, Journal of immunology.

[25]  K. Sugamura,et al.  Two distinct human cloned T cell lines that exhibit natural killer-like and anti-human effector activities. , 1982, Journal of immunology.

[26]  S. Mizel.  Interleukin l and T Cell Activation , 1982 .

[27]  R. North.  Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells , 1982, The Journal of experimental medicine.

[28]  John C. Lee,et al.  Interleukin 3: Possible Roles in the Regulation of Lymphocyte Differentiation and Growth , 1982, Immunological reviews.

[29]  W. Farrar,et al.  The Biochemistry, Biology, and Role of Interleukin 2 in the Induction of Cytotoxic T Cell and Antibody‐Forming B Cell Responses , 1982, Immunological reviews.

[30]  R. Palacios.  Mechanism of T Cell Activation: Role and Functional Relationship of HLA‐DR Antigens and Interleukins , 1982, Immunological reviews.

[31]  I. Gery,et al.  Interleukin 1 is more than an interleukin. , 1982, Immunology today.

[32]  S. Rosenberg,et al.  Lysis of fresh human solid tumors by autologous lymphocytes activated in vitro with lectins. , 1982, Cancer research.

[33]  J. Mier,et al.  The purification and properties of human T cell growth factor. , 1982, Journal of immunology.

[34]  B. Loveland,et al.  Which T cells cause graft rejection , 1982 .

[35]  D. Katz,et al.  Constitutive and mitogen-induced production of T cell growth factor by stable T cell hybridoma lines. , 1982, Journal of immunology.

[36]  E. Fernandez-cruz,et al.  Immunotherapy of a chemically-induced sarcoma in rats: characterization of the effector T cell subset and nature of suppression. , 1982, Journal of immunology.

[37]  S. Bartlett,et al.  Studies on natural killer (NK) cells. III. The effects of in vitro culture on spontaneous cytotoxicity of murine spleen cells. , 1982, Journal of immunology.

[38]  M. Mokyr,et al.  Role of antitumor immunity in cyclophosphamide-induced rejection of subcutaneous nonpalpable MOPC-315 tumors. , 1982, Cancer research.

[39]  D. Neville,et al.  Bone marrow transplantation across major histocompatibility barriers. V. Protection of mice from lethal graft-vs.-host disease by pretreatment of donor cells with monoclonal anti-Thy-1.2 coupled to the toxin ricin , 1982, Journal of Experimental Medicine.

[40]  J. Uhr,et al.  Selective killing of leukaemia cells by antibody–toxin conjugates: implications for autologous bone marrow transplantation , 1982, Nature.

[41]  B. Loveland,et al.  Cells mediating graft rejection in the mouse. II. The Ly phenotypes of cells producing tumor allograft rejection. , 1982, Transplantation.

[42]  R. D. du Bois,et al.  Identification of human CML target. HLA-B locus (B12) antigen variants defined by CTL generated between B locus-identical (B12) responder-stimulator pairs. , 1982, Journal of immunology.

[43]  D. Knowles,et al.  OT-CLL: a human T cell chronic lymphocytic leukemia that produces IL 2 in high titer. , 1982, Journal of immunology.

[44]  I. Fidler,et al.  Involvement of macrophages in the eradication of established metastases following intravenous injection of liposomes containing macrophage activators. , 1982, Cancer research.

[45]  J. Ritz,et al.  Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen. , 1982, Cancer research.

[46]  A. Altman,et al.  Helper factor production in murine secondary syngeneic mixed leukocyte reactions. , 1982, Journal of immunology.

[47]  U. Koszinowski,et al.  T cell-specific suppressor factor(s) with regulatory influence on interleukin 2 production and function. , 1982, Journal of immunology.

[48]  E. Larsson.  Functional heterogeneity of helper T cells: two distinct helper T cells are required for the production of T cell growth factor. , 1982, Journal of immunology.

[49]  M. Beckwith,et al.  Suppressor-target interaction in alloantigen induced responses: induction of a second cell in the suppressive pathway. , 1982, Journal of immunology.

[50]  J. Marx.  Tumors; a mixed bag of cells. , 1982, Science.

[51]  J. Giorgi,et al.  Tumor immunity to murine plasma cell tumors. VII. Expression of H-2 and tumor antigens on Ig synthesis variants of MPC-11. , 1982, International journal of cancer.

[52]  G. Bonnard,et al.  Specific cytotoxicity against autologous tumour and proliferative responses of human lymphocytes grown in interleukin 2 , 1982, International journal of cancer.

[53]  G. Goldstein,et al.  Studies of thymopoietin pentapeptide (TP5) on experimental tumors. I. TP5 relieves immunosuppression in tumor-bearing mice. , 1982, Cellular immunology.

[54]  W. Falk,et al.  Interleukin 2 is not sufficient as helper component for the activation of cytotoxic T lymphocytes but synergizes with a late helper effect that is provided by irradiated I-region-incompatible stimulator cells. , 1982, Journal of immunology.

[55]  J. Cowens,et al.  In vitro effects of 4-hydroperoxycyclophosphamide on human immunoregulatory T subset function. I. Selective effects on lymphocyte function in T-B cell collaboration , 1982, The Journal of experimental medicine.

[56]  J. D. de Vries,et al.  Establishment of human T lymphocyte clones highly cytotoxic for an EBV-transformed B cell line in serum-free medium: isolation of clones that differ in phenotype and specificity. , 1982, Journal of immunology.

[57]  M. Masucci,et al.  Lysis of tumor biopsy cells by autologous T lymphocytes activated in mixed cultures and propagated with T cell growth factor , 1982, The Journal of experimental medicine.

[58]  M. Bevan,et al.  Antigen recognition by cloned cytotoxic T lymphocytes follows rules predicted by the altered-self hypothesis , 1982, The Journal of experimental medicine.

[59]  O. Stutman,et al.  Ia-dependent interleukin 2 production in syngeneic cellular interactions. , 1982, Journal of immunology.

[60]  J. Schrader,et al.  Biochemical characterization of regulatory factors derived from T cell hybridomas and spleen cells. I. Separation of T cell growth factor and T cell replacing factor from granulocyte-macrophage colony-stimulating factor. , 1982, Journal of immunology.

[61]  V. Paetkau.  Lymphokines on the move , 1981, Nature.

[62]  F. Bach,et al.  Antigen-driven helper cell-independent cloned cytolytic T lymphocytes , 1981, Nature.

[63]  U. Landegren,et al.  Cyclosporin A permits the distinction between specific T and NK activity generated in A human MLC , 1981, International journal of cancer.

[64]  P. Hersey,et al.  Induction of cytotoxic activity in human lymphocytes against autologous and allogeneic melanoma cells in vitro by culture with interleukin 2 , 1981, International journal of cancer.

[65]  M. Bevan,et al.  Specificity of T-cell clones illustrates altered self hypothesis , 1981, Nature.

[66]  V. Paetkau,et al.  Translation of lymphocyte mRNA into biologically-active Interleukin 2 in oocytes. , 1981, Journal of immunology.

[67]  J. Klein,et al.  Macrophage or T cell - that is the question. , 1981, Immunology today.

[68]  Kendall A. Smith,et al.  Heterogeneity of human T-cell growth factor(s) due to variable glycosylation. , 1981, Molecular immunology.

[69]  J. Finke,et al.  Generation of alloreactive cytotoxic T lymphocytes: production of T cell and macrophage helper factors in addition to IL 1 and IL 2 by peritoneal cells from mice immunized to Listeria monocytogenes. , 1981, Journal of immunology.

[70]  C. Weyand,et al.  Recognition of polymorphic H-2 domains by T lymphocytes. I. Functional role of different H-2 domains for the generation of alloreactive cytotoxic T lymphocytes and determination of precursor frequencies , 1981, The Journal of experimental medicine.

[71]  A. Houghton,et al.  Heterogeneity in surface antigen and glycoprotein expression of cell lines derived from different melanoma metastases of the same patient. Implications for the study of tumor antigens , 1981, The Journal of experimental medicine.

[72]  D. Kilburn,et al.  Characteristics of an antigen-specific helper factor that enhances the in vitro generation of cytotoxic cells directed against a syngeneic tumor. , 1981, Journal of immunology.

[73]  J. Levy,et al.  Accessory cells in the in vitro generation of type C virus-specific T killer lymphocytes. II. Demonstration of a T helper cell in the spleen of in vivo primed mice. , 1981, Journal of immunology.

[74]  J. Calafat,et al.  Molecular Heterogeneity of H‐2 Antigens , 1981, Immunological reviews.

[75]  I. Penn.  Depressed immunity and the development of cancer. , 1981, Clinical and experimental immunology.

[76]  H. Festenstein,et al.  Variation in MHC Antigenic Profiles of Tumor Cells and its Biological Effects , 1981, Immunological reviews.

[77]  T. Kishimoto,et al.  Establishment and characterization of human T hybrid cells secreting immunoregulatory molecules. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[78]  J. Klein,et al.  Ia Antigens as Restriction Molecules in Ir‐Gene Controlled T‐Cell Proliferation , 1981, Immunological reviews.

[79]  J. Klein,et al.  Polymorphism of the Mouse H‐2 Loci , 1981, Immunological reviews.

[80]  J. Levy,et al.  Quantitative variations in the expression of H-2 antigens on murine leukemia virus-induced tumor cells can affect the H-2 restriction patterns of tumor-specific cytolytic T lymphocytes , 1981, The Journal of experimental medicine.

[81]  J. Finke,et al.  The immunogenic and tumorigenic properties of a murine lymphoma that expresses foreign alloantigens: role of helper factor(s) in generating a cytotoxic response in vitro. , 1981, Transplantation proceedings.

[82]  G. Klein.  The role of gene dosage and genetic transpositions in carcinogenesis , 1981, Nature.

[83]  J. Marx.  T cells scrutinized at Rüdesheim meeting. , 1981, Science.

[84]  J. Mulé,et al.  Production of T‐cell lines with inhibitory or stimulatory activity against syngeneic tumors in vivo. A preliminary report , 1981, International journal of cancer.

[85]  T. Yamamoto,et al.  Preliminary observations of the effects on breast adenocarcinoma of plasma perfused over immobilized protein A. , 1981, The New England journal of medicine.

[86]  E. Reinherz,et al.  Antibody directed at a surface structure inhibits cytolytic but not suppressor function of human T lymphocytes , 1981, Nature.

[87]  R. Burton,et al.  Definitive evidence that natural killer (NK) cells inhibit experimental tumor metastases in vivo. , 1981, Journal of immunology.

[88]  A. Munck,et al.  T cell growth factor receptors. Quantitation, specificity, and biological relevance , 1981, The Journal of experimental medicine.

[89]  A. Gazdar,et al.  Human cutaneous T cell lymphoma and leukemia cell lines produce and respond to T cell growth factor , 1981, The Journal of experimental medicine.

[90]  R. Hopkins,et al.  Spontaneous release of a factor with properties of T cell growth factor from a continuous line of primate tumor T cells. , 1981, Journal of immunology.

[91]  S. Rosenberg,et al.  Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor. , 1981, Cancer research.

[92]  S. Swain.  Significance of Lyt phenotypes: Lyt2 antibodies block activities of T cells that recognize class 1 major histocompatibility complex antigens regardless of their function. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[93]  O. Stutman,et al.  Culture-generated suppressor cells: evidence for an adherent cell component. , 1981, Cellular immunology.

[94]  P. Wernet,et al.  Cloning of functional human T lymphocytes by limiting dilution: impact of filler cells and interleukin 2 sources on cloning efficiencies. , 1981, Scandinavian journal of immunology.

[95]  K. Clouse,et al.  Stimulation with autologous lymphoblastoid cell lines: lysis of Epstein-Barr virus-positive and -negative cell lines by two phenotypically distinguishable effector cell populations. , 1981, Journal of immunology.

[96]  F. Bach,et al.  SB: a new HLA-linked human histocompatibility gene defined using HLA-mutant cell lines , 1981, Nature.

[97]  J. Ortaldo,et al.  Natural killer cells: their roles in defenses against disease. , 1981, Science.

[98]  D. Kilburn,et al.  Helper cells active in the generation of cytotoxicity to a syngeneic tumor. , 1981, Journal of immunology.

[99]  M. Moore,et al.  Cultured human T-cell lines kill autologous solid tumours. , 1981, Immunology letters.

[100]  P. Fink,et al.  Influence of H-2 antigen expression on killer T cell specificity, differentiation, and induction. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[101]  B. Susskind,et al.  Effects of gamma-irradiation on lymphocyte subpopulations participating in the development of the cytotoxic T lymphocyte response. , 1981, Journal of immunology.

[102]  C. Henney,et al.  The role of interleukin-2 (IL-2) in the differentiatin of cytotoxic T cells: the effect of monoclonal anti-IL-2 antibody and absorption with IL-2 dependent T cell lines. , 1981, Journal of immunology.

[103]  R. North,et al.  T cell-mediated immunosuppression as an obstacle to adoptive immunotherapy of the P815 mastocytoma and its metastases , 1981, The Journal of experimental medicine.

[104]  J. Dausset.  The major histocompatibility complex in man. , 1981, Science.

[105]  C. Hardt,et al.  Impact of Thymus on the Generation of Immunocompetence and Diversity of Antigen‐Specific MHC‐Restricted Cytotoxic T‐Lymphocyte Precursors , 1981, Immunological reviews.

[106]  N. Minato,et al.  On the heterogeneity of murine natural killer cells , 1981, The Journal of experimental medicine.

[107]  C. Lutz.  The generation of cytolytic activity in mixed leukocyte cultures: cortisone-resistant thymocytes are deficient in helper T lymphocytes. , 1981, Journal of immunology.

[108]  D. Naor,et al.  Immune response to weakly immunogenic virally induced tumors. IX. Mice injected with the in vitro variant of YAC tumor (YAC-1) resist lethal doses of the tumorigenic YAC cells. , 1981, Immunobiology.

[109]  B. Malissen,et al.  Clones of Human Cytotoxic T Lymphocytes Derived from an Allosensitized Individual: HLA Specificity and Cell Surface Markers , 1981, Scandinavian journal of immunology.

[110]  B. Benacerraf,et al.  Induction, Control and Consequences of Virus Specific Cytotoxic T Cells , 1981, Immunological reviews.

[111]  J. Klein,et al.  Responder T cells depleted of alloreactive cells react to antigen presented on allogeneic macrophages from nonresponder strains , 1981, The Journal of experimental medicine.

[112]  F. Fitch.  T lymphocyte clones having defined immunological functions. , 1981, Transplantation.

[113]  R. Ciavarra,et al.  Cell Membrane Antigens Recognized by Anti‐Viral and Anti‐Trinitrophenyl Cytotoxic T Lymphocytes , 1981, Immunological reviews.

[114]  P. Greenberg,et al.  Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes , 1981, The Journal of experimental medicine.

[115]  J. Woody,et al.  Absolute requirement for adherent cells in the production of human interleukin 2 (IL2). , 1981, Cellular immunology.

[116]  H. Ertl,et al.  An Analysis of Effector T Cell Generation and Function in Mice Exposed to Influenza A or Sendai Viruses , 1981, Immunological reviews.

[117]  Wright Jt,et al.  Cryotherapy to prevent haemostasis after cone biopsy. , 1981 .

[118]  R. W. Baldwin,et al.  Tumour cells in metastatic deposits with altered sensitivity to natural killer cells , 1981, International journal of cancer.

[119]  E. Kedar,et al.  In vivo anti‐tumor effects of local adoptive transfer of mouse and human cultured lymphoid cells , 1981, International journal of cancer.

[120]  R. Good,et al.  TRANSPLANTATION FOR ACUTE LEUKAEMIA WITH HLA-A AND B NONIDENTICAL PARENTAL MARROW CELLS FRACTIONATED WITH SOYBEAN AGGLUTININ AND SHEEP RED BLOOD CELLS , 1981, The Lancet.

[121]  P. Matzinger.  A one-receptor view of T-cell behaviour , 1981, Nature.

[122]  K. Pfizenmaier,et al.  Lyt-23+ cyclophosphamide-sensitive T cells regulate the activity of an interleukin 2 inhibitor in vivo , 1981, The Journal of experimental medicine.

[123]  D. Strong,et al.  Clinical effects of infusions into chimpanzees of primed autologous cultured T-cells. , 1981, Journal of the National Cancer Institute.

[124]  U. Yamashita,et al.  The requirement of Ia-positive accessory cells for the induction of tumor-specific cytotoxic T lymphocytes in vitro. , 1981, Cellular immunology.

[125]  G. Shearer,et al.  T cell subpopulations required for the human cytotoxic T lymphocyte response to influenza virus: evidence for T cell help. , 1981, Journal of immunology.

[126]  J. Vassalli,et al.  Purification of murine T cell growth factor. A lymphocyte mitogen with helper activity , 1981, The Journal of experimental medicine.

[127]  H. Macdonald,et al.  Quantitation and clonal isolation of cytolytic T lymphocyte precursors selectively infiltrating murine sarcoma virus-induced tumors , 1981, The Journal of experimental medicine.

[128]  T. Eberlein,et al.  In vitro growth of murine T cells. VI. Accelerated skin graft rejection caused by adoptively transferred cells expanded in T cell growth factor. , 1981, Journal of immunology.

[129]  L. Moretta,et al.  Surface markers of cloned human T cells with various cytolytic activities , 1981, The Journal of experimental medicine.

[130]  V. Schirrmacher,et al.  Escape of metastasizing clonal tumor cell variants from tumor-specific cytolytic T lymphocytes , 1981, The Journal of experimental medicine.

[131]  W. Boyle,et al.  Binding of MLR precursors requires immunosorbents which present both self- and alloantigen , 1981, Nature.

[132]  C. Rosse,et al.  The dependence of tumor neutralization on bone‐marrow‐derived cells , 1981, International journal of cancer.

[133]  C. Feighery,et al.  Cell mediated cytotoxicity against HLA-D region products expressed in monocytes and B lymphocytes. III. Inhibition by monoclonal antibodies and study of an HLA-B/DR recombinant. , 1981, Human immunology.

[134]  B. Malissen,et al.  Cloned cytotoxic T lymphocytes: A new, complementary approach to HLA-typing , 1981 .

[135]  John C. Lee,et al.  Establishment of continuous cultures of Thy1.2+, Lytl+,2−T cells with purified interleukin 3 , 1981, Cell.

[136]  P. Greenberg,et al.  Adoptive therapy of established syngeneic leukemia by cells primarily sensitized in vitro. , 1981, Cancer research.

[137]  G. Klein,et al.  Epstein Barr virus selective T cells in infectious mononucleosis are not restricted to HLA-A and B antigens. , 1981, Journal of immunology.

[138]  J. Frelinger,et al.  T lymphocyte responses to non-H-2 histocompatibility antigens. I. Role of Ly-1+2+ T cells as cytotoxic effectors and requirement for Ly-1+2+ T cells for optimal generation of cytotoxic effectors. , 1981, Journal of immunology.

[139]  G. Dennert,et al.  T cells may express multiple activities: specific allohelp, cytolysis, and delayed-type hypersensitivity are expressed by a cloned T-cell line. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[140]  P. Greenberg,et al.  Chemoimmunotherapy of a Friend leukemia with cells secondarily sensitized in vitro: effect of culture duration on therapeutic efficacy. , 1981, Journal of the National Cancer Institute.

[141]  E. Sabbadini,et al.  Effect of Bacillus Calmette-Guérin on the in vitro generation of cytotoxic T lymphocytes. I. Effect of BCG on the frequency of cytotoxic T lymphocyte precursors and on the production of helper factors. , 1981, Journal of immunology.

[142]  S. Rosenberg,et al.  Lysis of human solid tumors by autologous cells sensitized in vitro to alloantigens. , 1981, Journal of immunology.

[143]  K. Sullivan,et al.  Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. , 1981, The New England journal of medicine.

[144]  B. Benacerraf.  Role of MHC gene products in immune regulation. , 1981, Science.

[145]  J. Klein,et al.  The traditional and a new version of the mouse H–2 complex , 1981, Nature.

[146]  M. Poupon,et al.  Adoption of tumor immunity: role of the major histocompatibility complex. , 1981, Journal of immunology.

[147]  P. Russell,et al.  T CELL RESPONSES TO ALLOANTIGENS II. IN VITRO INDUCTION OF SPECIFIC Ts BY HEAT‐INACTIVATED ALLOGENEIC LYMPHOID CELLS , 1981, Transplantation.

[148]  P. Greenberg,et al.  H-2 restriction of adoptive immunotherapy of advanced tumors. , 1981, Journal of immunology.

[149]  S. Swain.  Significance of class 1 and class 2 major histocompatibility complex antigens: help to allogeneic K and D antigens does not involve I recognition. , 1981, Journal of immunology.

[150]  S. Rosenberg,et al.  In vitro growth of cytotoxic human lymphocytes. III. The preparation of lectin-free T cell growth factor (TCGF) and an analysis of its activity. , 1981, Journal of immunology.

[151]  C. Henney,et al.  Murine NK cell cultures: effects of interleukin-2 and interferon on cell growth and cytotoxic reactivity. , 1981, Journal of immunology.

[152]  G. Nabel,et al.  Multiple activities of a cloned cell line mediating natural killer cell function , 1981, The Journal of experimental medicine.

[153]  E. Gorelik,et al.  Radioisotope assay for evaluation of in vivo natural cell‐mediated resistance of mice to local transplantation of tumor cells , 1981, International journal of cancer.

[154]  Watson Jd.  Lymphokines and the induction of immune responses. , 1981 .

[155]  B. Loveland,et al.  Cells mediating graft rejection in the mouse. I. Lyt-1 cells mediate skin graft rejection , 1981, The Journal of experimental medicine.

[156]  S. Gillis,et al.  Constitutive production of interleukin 2 activity by a T cell hybridoma. , 1981, Journal of immunology.

[157]  I. Fidler,et al.  The origin of metastatic heterogeneity in tumors. , 1981, European journal of cancer.

[158]  B. Chapuis,et al.  Human spleen as a source of T cell growth factor. , 1981, Clinical and experimental immunology.

[159]  J. Petit,et al.  High dose chemotherapy and autologous bone marrow transplantation in acute leukemias, malignant lymphomas and solid tumors. A study of 23 patients. , 1981, European journal of cancer.

[160]  P. Marrack,et al.  Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition , 1981, The Journal of experimental medicine.

[161]  T. Braciale,et al.  Simultaneous expression of H-2-restricted and alloreactive recognition by a cloned line of influenza virus-specific cytotoxic T lymphocytes , 1981, The Journal of experimental medicine.

[162]  L. Bradley,et al.  Differential effects of glucocorticosteroids on the functions of helper and suppressor T lymphocytes (immune regulation/dexamethasone/macrophage factors/T cell growth factors/autoimmunity) , 2016 .

[163]  B. Klein,et al.  Immunogenicity of subcellular fractions and molecular species of MuLV-induced tumors. II. Stimulation of syngeneic antitumor cell-mediated immune responses by subcellular fractions and molecular species of the Rauscher-virus-induced RBL5 tumor. , 1981, Journal of immunology.

[164]  R. Palacios,et al.  T cell growth factor abrogates concanavalin A-induced suppressor cell function , 1981, The Journal of experimental medicine.

[165]  H. Schellekens,et al.  Induction of Natural Killer Cell Activity and Allocytotoxicity in Human Peripheral Blood Lymphocytes after Mixed Lymphocyte Culture , 1981, Scandinavian journal of immunology.

[166]  S. Rosenberg,et al.  A simplified method for the production of murine T-cell growth factor free of lectin. , 1981, Journal of immunological methods.

[167]  N. Sinclair,et al.  Cell-mediated cytotoxicity against syngeneic tumors. , 1981, Cellular immunology.

[168]  P. Greenberg,et al.  Specific adoptive therapy of established leukemia with syngeneic lymphocytes sequentially immunized in vivo and in vitro and nonspecifically expanded by culture with Interleukin 2. , 1981, Journal of immunology.

[169]  S. Argov,et al.  Tumor biopsy cells participating in systems in which cytotoxicity of lymphocytes is generated. Autologous and allogeneic studies , 1981, International journal of cancer.

[170]  J. Levy,et al.  Accessory cells in the in vitro generation of type C viruses specific T killer lymphocytes. I. Role of macrophages in primary anti-FMR reaction. , 1981, Journal of immunology.

[171]  H. Kolb,et al.  Antileukemic, autologous bone marrow transplantation in childhood acute lymphoblastic leukemia. , 1981, Transplantation proceedings.

[172]  P. Wernet,et al.  Different functions of human cloned T-cell lines in PLT, cytotoxicity and allogeneic suppression correlated with distinct cell surface determinants detected by monoclonal antibodies. , 1981, Transplantation proceedings.

[173]  K. Sullivan,et al.  Antileukemic effect of graft-versus-host disease contributes to improved survival after allogeneic marrow transplantation. , 1981, Transplantation proceedings.

[174]  A. Zander,et al.  Autologous bone marrow transplantation in neoplasia. , 1981, Transplantation proceedings.

[175]  M. Schlaak,et al.  Preparation of xenogeneic antibodies eliminating lymphocytes from human bone marrow selectively. , 1981, Transplantation proceedings.

[176]  R. Burton,et al.  Helper factor(s) augment in vitro induction of tumor-specific immunity. , 1981, Cellular immunology.

[177]  J. Schrader,et al.  T cell hybridoma-derived regulatory factors. I. Production of T cell growth factor following stimulation by concanavalin A. , 1981, Journal of immunology.

[178]  R. Daynes,et al.  Mycoplasma-mediated activation of normal mouse lymphocytes: induction of cytotoxic lymphocytes and lymphocyte transformation by Mycoplasma arthritidis are under Ir gene control. , 1981, Journal of immunology.

[179]  Z. Nagy,et al.  Physiology of alloreactivity: an interpretation. , 1981, Transplantation proceedings.

[180]  R. Gallo,et al.  RC Gallo lymphocytes Human T-lymphocyte growth factor : regulation of growth and function of T , 1981 .

[181]  B. Benacerraf,et al.  Antigen-presenting cell function in induction of helper T cells for cytotoxic T-lymphocyte responses: evidence for antigen processing. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[182]  D. Lannin,et al.  T cells must recognize tumor antigen in association with self-MHC antigen. , 1981, Transplantation proceedings.

[183]  W. Farrar,et al.  Regulation of the production of immune interferon and cytotoxic T lymphocytes by interleukin 2. , 1981, Journal of immunology.

[184]  J. Najarian,et al.  Total lymphoid irradiation and kidney transplantation: a clinical experience. , 1981, Transplantation proceedings.

[185]  E. Klein.  Central issues in present-day tumor immunology: interpretation of lymphocytotoxicity assays and the demonstration of auto-tumor-reactive lymphocytes in patients. , 1981, Transplantation proceedings.

[186]  B. Klein,et al.  Isolation of immunogenic and suppressogenic determinants of the nonimmunogenic YAC tumor and the change in its immunogenic repertoire after in vitro cultivation. , 1981, Transplantation proceedings.

[187]  S. Bartlett,et al.  Heterogeneity of natural killer cells in the mouse , 1981, The Journal of experimental medicine.

[188]  G. Dennert,et al.  Cloned cell lines with natural killer activity. Specificity, function, and cell surface markers , 1981, The Journal of experimental medicine.

[189]  J. Ortaldo,et al.  Characteristics of human large granular lymphocytes and relationship to natural killer and K cells , 1981, The Journal of experimental medicine.

[190]  H. Warren,et al.  A method for the production and quantitative assay of human lymphokine preparations. , 1981, Journal of immunological methods.

[191]  C. Rosse,et al.  Tumor neutralization by immune in vitro‐sensitized splenocytes depends on an interaction with bone‐marrow‐derived cells , 1981, International journal of cancer.

[192]  A. Silva,et al.  Removal of PHA from supernatants containing T-cell growth factor. , 1981, Journal of immunological methods.

[193]  B. Dupont,et al.  Cloning and Characterization of Primary Alloreactive Human T‐Lymphocytes , 1981, Immunological reviews.

[194]  L. Old.  Cancer immunology: the search for specificity--G. H. A. Clowes Memorial lecture. , 1981, Cancer research.

[195]  C. Lutz,et al.  Murine T Lymphocyte Clones with Distinct Immunological Functions , 1981, Immunological reviews.

[196]  A. Goldin,et al.  Drug-mediated increase of tumor immunogenicity in vivo for a new approach to experimental cancer immunotherapy. , 1981, Cancer research.

[197]  F. Bach,et al.  Cloned Cytotoxic and Non‐Cytotoxic Lymphocytes in Mouse and Man: Their Reactivities and a Large Cell Surface Membrane Protein (LMP) Differentiation Marker System , 1981, Immunological reviews.

[198]  H. Macdonald,et al.  Limiting dilution analysis of alloantigen-reactive T lymphocytes. V. Lyt phenotype of cytolytic T lymphocyte precursors reactive against normal and mutant H-2 antigens. , 1981, Journal of immunology.

[199]  N. Sinclair,et al.  Inhibition of an vitro cell-mediated response: further experiments on the cell lineage and target of suppressor cells. , 1981, Cellular immunology.

[200]  N. Schaaf-Lafontaine,et al.  FCS-activated blast T cells inhibit the in vitro response of memory CTL precursors to alloantigens by removal of factor(s) from MLC supernatant. , 1981, Journal of immunology.

[201]  H. Boehmer,et al.  H‐2 Restricted Cytolytic and Noncytolytic T Cell Clones: Isolation, Specificity and Functional Analysis , 1981, Immunological reviews.

[202]  S. Gillis,et al.  Interleukin‐2 Dependent Culture of Cytolytic T Cell Lines , 1981, Immunological reviews.

[203]  M. Lipinski,et al.  Evolutionary conservation of surface molecules that distinguish T lymphocyte helper/inducer and cytotoxic/suppressor subpopulations in mouse and man , 1981, The Journal of experimental medicine.

[204]  J. Cairns.  The origin of human cancers , 1981, Nature.

[205]  P. Debré,et al.  T cell‐mediated immunity to oncornavirus‐induced tumors III. Specific and nonspecific suppression in tumor‐bearing mice , 1981, European journal of immunology.

[206]  V. Paetkau,et al.  EFFECT OF A MONOCLONAL ANTI‐LYT-1.1 ON THE FUNCTIONAL ACTIVITY OF PRECURSOR, EFFECTOR, AND REGULATORY CELLS SPECIFIC FOR MURINE ALLOANTIGENS , 1981, Transplantation.

[207]  F. Bach,et al.  Sensitization of lymphocytes against pooled allogeneic cells. II. Characterization of effector cells cytotoxic for autologous lymphoblastoid cell lines. , 1981, Journal of immunology.

[208]  J. Giorgi,et al.  Continuous cytotoxic T cell lines reactive against murine plasmacytoma tumor-associated antigens. , 1981, Journal of immunology.

[209]  P. Greenberg,et al.  Distinct phenotypic expression of immunogenicity and immunosensitivity in sublines of a tumor. , 1981, Journal of immunology.

[210]  J. Watson,et al.  Biochemical separation of interleukin 2. , 1980, Journal of immunological methods.

[211]  P. Greenberg,et al.  Detection of early and delayed antitumor effects following curative adoptive chemoimmunotherapy of established leukemia. , 1980, Cancer research.

[212]  T. Braciale,et al.  Sendai virus-specific, H-2-restricted cytotoxic T lymphocyte responses of nude mice grafted with allogeneic or semi-allogeneic thymus glands , 1980, The Journal of experimental medicine.

[213]  B. Stadler,et al.  Thymoma production of T cell growth factor (Interleukin 2). , 1980, Journal of immunology.

[214]  D. Przepiorka,et al.  Effect of polyethylene glycol 6000 on the generation of antitumor cytotoxicity in MOPC-315 tumor bearer spleen cells cultured in the presence or absence of inactivated stimulator tumor cells. , 1980, Cancer research.

[215]  J. Watson,et al.  Biochemical and biologic characterization of lymphocyte regulatory molecules. III. The isolation and phenotypic characterization of Interleukin-2 producing T cell lymphomas. , 1980, Journal of immunology.

[216]  B. Klein,et al.  Immunogenicity of subcellular fractions and molecular species of MuLV-induced tumors. I. screening of immunogenic components by isopycnic ultracentrifugation and polyacrylamide electrophoresis of a tumor homogenate , 1980 .

[217]  P. Kung,et al.  Monoclonal antibodies which distinguish between human NK cells and cytotoxic T lymphocytes , 1980, Nature.

[218]  H. Kirchner,et al.  Interferon production in cocultures between mouse spleen cells and tumor cells: possible role of mycoplasmas in interferon induction. , 1980, Journal of immunological methods.

[219]  S. Segal,et al.  Differential expression of H–2 gene products in tumour cells is associated with their metastatogenic properties , 1980, Nature.

[220]  S. Shimizu,et al.  Mitogen-initiated synthesis and secretion of T cell growth factor(s) by a T-lymphoma cell line , 1980, The Journal of experimental medicine.

[221]  J. Ortaldo,et al.  Selective depletion of human natural killer cells on monolayers of target cells. , 1980, Journal of immunology.

[222]  A. Weiss,et al.  Antigenic specificity of the cytolytic T lymphocyte response to murine sarcoma virus-induced tumors. III. Characterization of cytolytic T lymphocyte clones specific for Moloney leukemia virus-associated cell surface antigens , 1980, The Journal of experimental medicine.

[223]  G. Mills,et al.  Generation of cytotoxic lymphocytes to syngeneic tumors by using co-stimulator (Interleukin 2): in vivo activity. , 1980, Journal of immunology.

[224]  G. Mills,et al.  Generation of cytotoxic lymphocytes to syngeneic tumor by using co-stimulator (Interleukin 2). , 1980, Journal of immunology.

[225]  H. Teh,et al.  The use of a clonal assay for cytotoxic T lymphocytes to determine the Ly phenotypes of the cytotoxic precursor and effector cells to alloantigens and trinitrophenyl-modified self antigens. , 1980, Journal of immunology.

[226]  F. Bach,et al.  The role of gp70 in the target antigen recognized by murine leukemia virus immune cytotoxic T‐lymphocytes , 1980, International journal of cancer.

[227]  D. Ballinari,et al.  Expression of alien minor histocompatibility antigens distinct from tumor‐specific transplantation antigen on a murine fibrosarcoma , 1980, International journal of cancer.

[228]  J. Mier,et al.  Purification and some characteristics of human T-cell growth factor from phytohemagglutinin-stimulated lymphocyte-conditioned media. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[229]  A. Eggers,et al.  Chemical enhancement of tumor immunogenicity. , 1980, Journal of immunology.

[230]  B. Benacerraf,et al.  Cellular interactions in the generation of cytolytic T lymphocyte responses: role of Ia-positive splenic adherent cells in presentation in H-2 antigen. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[231]  R. Gorczynski,et al.  Individual‐specific (idiotypic) T‐B cell interactions regulating the production of anti‐2,4,6‐trinitrophenyl antibody. I. Generation of suppressor T cells and antibody directed against immunocompetent cells , 1980, European journal of immunology.

[232]  D. Mathisen,et al.  The in vivo distribution of autologous human and murine lymphoid cells grown in T cell growth factor (TCGF): implications for the adoptive immunotherapy of tumors. , 1980, Journal of immunology.

[233]  P. Marrack,et al.  Concanavalin A-inducible, interleukin-2-producing T cell hybridoma , 1980, The Journal of experimental medicine.

[234]  H. Hengartner,et al.  Characterization of cloned murine cytolytic T cell lines. , 1980, Journal of immunology.

[235]  B. Woda,et al.  Elimination of syngeneic sarcomas in rats by a subset of T lymphocytes , 1980, The Journal of experimental medicine.

[236]  G. Trinchieri,et al.  Interferon production by human and murine lymphocytes in response to alloantigens. , 1980, Journal of immunology.

[237]  G. Dennert.  Cloned lines of natural killer cells , 1980, Nature.

[238]  J. Klein,et al.  The mouse-primed lymphocyte typing test. III. Dissociation of T lymphocyte-stimulating determinants and antibody-defined specificities of the I region-associated Ia antigens. , 1980, Journal of immunology.

[239]  J. Strominger,et al.  Development and characterization of allospecific long-term human cytolytic T-cell lines. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[240]  G. Shearer,et al.  Evidence for a new segregant series of B cell antigens that are encoded in the HLA-D region and that stimulate secondary allogenic proliferative and cytotoxic responses , 1980, The Journal of experimental medicine.

[241]  B. Chesebro,et al.  Cytotoxic T lymphocyte recognition of gp70 on Friend virus-induced erythroleukemia cell clones. , 1980, Journal of immunology.

[242]  I. Weissman,et al.  Blocking effect of lyt-2 antibodies on T cell functions , 1980, The Journal of experimental medicine.

[243]  G. Csako,et al.  Cloning of human lymphocytes reactive with autologous leukemia cells. , 1980, Cancer research.

[244]  S. Rosenberg,et al.  In vitro growth of murine T cells. IV. Use of T-cell growth factor to clone lymphoid cells. , 1980, Cellular immunology.

[245]  P. Mühlradt,et al.  Mitogenic effects of partially purified interleukin 2 on thymocyte subpopulations and spleen T cells of the mouse , 1980, European journal of immunology.

[246]  M. Greene,et al.  The relationship between tumor antigens and alloantigens: cross-reactivity due to differential context of T cell antigen recognition. , 1980, Journal of immunology.

[247]  L. Nadler,et al.  A monoclonal antibody defining a lymphoma-associated antigen in man. , 1980, Journal of immunology.

[248]  D. Katz,et al.  The Induction of Autoreactive T Lymphocytes by Allogeneic Effect Factor (AEF): Relevance to Normal Pathways of Lymphocyte Differentiation , 1980, Immunological reviews.

[249]  D. Mochizuki,et al.  Interleukin 2: A Class of T Cell Growth Factors , 1980, Immunological reviews.

[250]  W. Green,et al.  Specificity of cytolytic T cells directed against AKR/Gross virus-induced syngeneic leukemias: antibodies directed against H-2K, but not against viral proteins, inhibit lysis. , 1980, Journal of immunology.

[251]  R. Burton,et al.  Tumor immunity to murine plasma cell tumors. V. Genetic control of the in vitro cytotoxic T-cell response to plasma cell tumor-associated antigens of NZB mice. , 1980, Journal of the National Cancer Institute.

[252]  H. Hengartner,et al.  Established Murine Cytolytic T‐Cell Lines as Tools for a Somatic Cell Genetic Analysis of T‐Cell Functions , 1980, Immunological reviews.

[253]  P. Greenberg,et al.  Specificity of adoptive chemoimmunotherapy of established syngeneic tumors. , 1980, Journal of immunology.

[254]  L. Herzenberg,et al.  T cell subsets defined by expression of Lyt-1,2,3 and Thy-1 antigens. Two-parameter immunofluorescence and cytotoxicity analysis with monoclonal antibodies modifies current views , 1980, The Journal of experimental medicine.

[255]  C. Taswell,et al.  Quantitation and Cloning of Cytolytic T Lymphocytes and their Precursors , 1980, Immunological reviews.

[256]  M. Schreier,et al.  Clones of Killer and Helper T Cells: Growth Requirements, Specificity and Retention of Function in Long‐Term Culture , 1980, Immunological reviews.

[257]  W. Solbach,et al.  T‐T Cell Interactions during Cytotoxic T Lymphocyte (CTL) Responses: T Cell Derived Helper Factor (Interleukin 2) as a Probe to Analyze CTL Responsiveness and Thymic Maturation of CTL Progenitors , 1980, Immunological reviews.

[258]  V. Paetkau,et al.  Cellular Origins and Targets of Costimulator (IL2) , 1980, Immunological reviews.

[259]  M. Mokyr,et al.  Importance of timing in cyclophosphamide therapy of MOPC-315 tumor-bearing mice. , 1980, Cancer research.

[260]  M. Glaser.  Indomethacin‐sensitive suppressor cells regulate the cell‐mediated cytotoxic response to SV 40‐induced tumor‐associated antigens in mice , 1980, European journal of immunology.

[261]  J. H. Pope,et al.  HLA antigen-related restriction of T lymphocyte cytotoxicity to Epstein-Barr virus. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[262]  S. Rosenberg,et al.  In vitro growth of murine T cells. V. The isolation and growth of lymphoid cells infiltrating syngeneic solid tumors. , 1980, Journal of immunology.

[263]  C. Ting,et al.  Switching on the macrophage-mediated suppressor mechanism by tumor cells to evade host immune surveillance. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[264]  O. Alaba,et al.  Specific induction of syngeneic cytotoxic T lymphocytes by solubilized tumor antigen: fractionation of the specific R-MuLV-induced leukemia antigen. , 1980, Journal of immunology.

[265]  C. Henney,et al.  The differentiation of cytotoxic T cells in vitro. II. Amplifying factor(s) produced in primary mixed lymphocyte cultures against K/D stimuli require the presence of Lyt 2+ cells but not Lyt 1+ cells. , 1980, Journal of immunology.

[266]  G. Berke.  Interaction of cytotoxic T lymphocytes and target cells. , 1980, Progress in allergy.

[267]  I. Fidler.  Therapy of spontaneous metastases by intravenous injection of liposomes containing lymphokines. , 1980, Science.

[268]  O. Alaba.  Specific enhancement of immune responses by BCG: isolation of extracellular DNA from supernatants of specifically stimulated BCG-primed lymphoid cells. , 1980, Journal of immunology.

[269]  S. Rosenberg,et al.  In vitro growth of cytotoxic human lymphocytes. II. Use of T cell growth factor (TCGF) to clone human T cells. , 1980, Journal of immunology.

[270]  E. Yefenof,et al.  In vitro generation of cytotoxic lymphocytes against radiation and radiation leukemia virus-induced tumors. I. Role of viral antigenicity. , 1980 .

[271]  H. Teh,et al.  Direct evidence for a two-signal mechanism of cytotoxic T-lymphocyte activation , 1980, Nature.

[272]  C. Orosz,et al.  H-2K/H-2D and Mls and I region-associated antigens stimulate helper factor(s) involved in the generation of cytotoxic T lymphocytes. , 1980, Journal of immunology.

[273]  M. Glaser.  Macrophage requirement for in vitro generation of specific, secondary cell‐mediated cytotoxicity against SV40‐induced tumor‐associated antigens in mice , 1980, European journal of immunology.

[274]  L. Old,et al.  Alloantigen-induced T-cell proliferation: Lyt phenotype of responding cells and blocking of proliferation by Lyt antisera. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[275]  S. Argov,et al.  Role of alloantigens in natural killing. Allogeneic but not autologous tumor biopsy cells are sensitive for interferon-induced cytotoxicity of human blood lymphcoytes , 1980, The Journal of experimental medicine.

[276]  O. Stutman,et al.  Natural cytotoxic cells against solid tumors in mice: blocking of cytotoxicity by D-mannose. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[277]  R. Wiltrout,et al.  Cell-mediated cytotoxic responses induced in vivo and in vitro by a metastatic murine tumor. , 1980, Journal of immunology.

[278]  D. Mathisen,et al.  The in vivo distribution of transferred syngeneic, allogeneic, and xenogeneic lymphoid cells: implication for the adoptive immunotherapy of tumors. , 1980, Journal of immunology.

[279]  R. Miller,et al.  Specific spontaneous cytotoxic activity in human T cell colonies. , 1980, Journal of immunology.

[280]  L. Gooding,et al.  Solubilization of complexes between tumor‐associated and H‐2 antigens from a tumor cell plasma membrane , 1980, European journal of immunology.

[281]  V. Paetkau,et al.  Cellular origins of co-stimulator (IL2) and its activity in cytotoxic T lymphocyte responses. , 1980, Journal of immunology.

[282]  G. Bonnard,et al.  Continued growth of functional human T lymphocytes: production of human T-cell growth factor. , 1980, Cellular immunology.

[283]  A. Glasebrook,et al.  Alloreactive cloned T cell lines. I. Interactions between cloned amplifier and cytolytic T cell lines , 1980, The Journal of experimental medicine.

[284]  R. Siliciano,et al.  H-2 restriction: independent recognition of H-2 and foreign antigen by a single receptor. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[285]  M. Röllinghoff,et al.  Fine Specificity and Cytolytic Activity of Continuously Growing Alloreactive Cytotoxic T Lymphocyte Clones , 1980, Scandinavian journal of immunology.

[286]  R. Bablanian,et al.  Inductive requirements for the generation of virus-specific T lymphocytes. III. Production of target cells lysable by poxvirus-specific and allospecific cytotoxic T lymphocytes with membrane fragments bearing viral and H-2 antigens. , 1980, Journal of immunology.

[287]  B. Benacerraf,et al.  The origins of alloreactivity: differentiation of prekiller cells to viral infection results in alloreactive cytolytic T lymphocytes. , 1980, Journal of immunology.

[288]  K. Heeg,et al.  T-cell-derived helper factor allows in vivo induction of cytotoxic T cells in nu/nu mice , 1980, Nature.

[289]  E. Reinherz,et al.  A monoclonal antibody reactive with the human cytotoxic/suppressor T cell subset previously defined by a heteroantiserum termed TH2. , 1980, Journal of immunology.

[290]  C. Ting,et al.  Immunoregulatory circuit among macrophage subsets for T cell-mediated cytotoxic response to tumor cells. , 1980, Journal of immunology.

[291]  McAlack Rf.  Normal HLA phenotypes and neo-HLA-like antigens on cultured human neuroblastoma. , 1980 .

[292]  F. Milgrom.  Antigens of vertebrate cells, tissues, and body fluids. , 1980, Transplantation proceedings.

[293]  W. Farrar,et al.  Participation of lymphocyte activating factor (Interleukin 1) in the induction of cytotoxic T cell responses. , 1980, Journal of immunology.

[294]  K. Tomonari.  Cytotoxic T cells generated in the autologous mixed lymphocyte reaction. I. Primary autologous mixed lymphocyte reaction. , 1980, Journal of immunology.

[295]  E. Appella,et al.  Alien H-2 antigens (H-2k) appearing on a methylcholanthrene-induced tumor (H-2d): biochemical characterization. , 1980, Transplantation proceedings.

[296]  B. Pope,et al.  Clinical experience in transplantation of the duct-ligated pancreas segment. , 1980 .

[297]  A. Coutinho,et al.  Two distinct factors are required for induction of T-cell growth , 1980, Nature.

[298]  L. Olsson,et al.  Autoreactive natural killer-like cells from agar-cloned murine bone marrow cells , 1980, Nature.

[299]  A. Glasebrook,et al.  Cell surface polypeptides of murine T-cell clones expressing cytolytic or amplifier activity. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[300]  J. Bennett,et al.  Opposite effects of different strains or batches of same strain of BCG on in vitro generation of syngeneic and allogeneic antitumor cytotoxicity. , 1980, Journal of the National Cancer Institute.

[301]  H. Cantor,et al.  T cell-mediated immunity to oncornavirus-induced tumors. II. Ability of different T cell sets to prevent tumor growth in vivo. , 1980, Journal of immunology.

[302]  H. Cantor,et al.  T cell-mediated immunity to oncornavirus-induced tumors. I. Ly phenotype of precursor and effector cytolytic T lymphocytes. , 1980, Journal of immunology.

[303]  G. Shearer,et al.  The self determinants recognized by human virus-immune T cells can be distinguished from the serologically defined HLA antigens. , 1980, Journal of immunology.

[304]  J. Wunderlich,et al.  Susceptibility of adherent versus suspension target cells derived from adherent tissue culture lines to cell-mediated cytotoxicity in rapid 51Cr-release assays. , 1980, Journal of immunological methods.

[305]  F. Bach,et al.  Lysis of syngeneic solid tumor cells by alloantigen stimulated mouse T and non-T cells. , 1980, Journal of immunology.

[306]  R. Wank,et al.  Genetic Specificity of Primary and Secondary Proliferative and Cytotoxic Responses of Human Lymphocytes Grown in Continued Culture , 1980, Scandinavian journal of immunology.

[307]  H. Macdonald,et al.  Limiting dilution analysis of alloantigen-reactive T lymphocytes. IV. High frequency of cytolytic T lymphocyte precursor cells in MLC blasts separated by velocity sedimentation. , 1980, Journal of immunology.

[308]  R. North,et al.  T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor , 1980, The Journal of experimental medicine.

[309]  R. W. Baldwin,et al.  Tumour-derived lymphoid cells prevent tumour growth in Winn assays. , 1979, British Journal of Cancer.

[310]  A. Eggers,et al.  Cell-mediated cytotoxic responses of spleen cells from mice bearing primary, chemically induced tumors. , 1979, Journal of immunology.

[311]  F. Bach,et al.  Lyt phenotypes of responding cells in secondary alloantigen responses. , 1979, Journal of immunology.

[312]  R. Huebner,et al.  Prevention of transplantable tumors by adoptive transfer of spleen cells from immunized rats. , 1979, Journal of immunology.

[313]  B. Bonavida,et al.  Mechanism of cell-mediated cytotoxicity at the single cell level. I. Estimation of cytotoxic T lymphocyte frequency and relative lytic efficiency. , 1979, Journal of immunology.

[314]  G. Shearer,et al.  Xenogeneic serum-induced murine cytotoxic cells. I. The generation of effector components specific for self and allogeneic target cells. , 1979, Cellular immunology.

[315]  T. Taniyama,et al.  In vitro induction of T-lymphocyte-mediated cytotoxicity by infectious murine type C oncornaviruses , 1979, The Journal of experimental medicine.

[316]  L. Law,et al.  Rauscher leukemia virus‐induced tumor antigens: Complete separation from gp70, p30 and H‐2 , 1979, International journal of cancer.

[317]  M. Moore,et al.  Suppressor cell activity of lymphocytes infiltrating human lung and breast tumours , 1979, International journal of cancer.

[318]  N. Wivel,et al.  Suppression of T cell‐mediated immunity by tumor cells: Immunogenicity versus immunosuppression and preliminary characterization of the suppressive factors , 1979, International journal of cancer.

[319]  E. Kedar,et al.  Immune response to weakly immunogenic virally induced tumors. IV. Dissociated recognition of H-2 and tumor-associated antigens. , 1979, Transplantation.

[320]  M. Glaser.  Collaboration between distinct subpopulations of T cells in in vitro generation of effector cells capable of growth prevention of syngeneic SV40-induced sarcoma in mice. , 1979, Cellular immunology.

[321]  Z. Fuks,et al.  Transplantation tolerance across major histocompatibility barriers after total lymphoid irradiation. , 1979, Transplantation.

[322]  I. Bernstein,et al.  Potentiation of the in vitro specific cytotoxic response to syngeneic lymphoma cells by PPD-stimulated tuberculin sensitive cells. , 1979, Cellular immunology.

[323]  A. Rimm,et al.  Graft-versus-leukaemia reactivity induced by alloimmunisation without augmentation of graft-versus-host reactivity , 1979, Nature.

[324]  K. Kärre,et al.  Cytotoxic Thy 1,2-positive blasts with NK-like target selectivity in murine mixed lymphocyte cultures. , 1979, Journal of immunology.

[325]  F. Bach,et al.  The Availability for Recognition of Normal H‐2 Antigens by Cytotoxic T Lymphocytes on a Rauscher‐Virus‐transformed Cell, RBL‐5A , 1979, Scandinavian journal of immunology.

[326]  K. Lafferty,et al.  A High Frequency of Cytotoxic Precursor Cells for a Syngeneic Tumour , 1979, Scandinavian journal of immunology.

[327]  E. Fernandez-cruz,et al.  In vivo elimination by specific effector cells of an established syngeneic rat moloney virus-induced sarcoma. , 1979, Journal of immunology.

[328]  R. Zawatzky,et al.  Production of interferon in the murine mixed lymphocyte culture. II. Interferon production is a T cell‐dependent function, independent of proliferation , 1979, European journal of immunology.

[329]  M. Pla,et al.  H‐2 restriction for lymphocyte homing into lymph nodes , 1979, European journal of immunology.

[330]  F. Bach,et al.  Human T lymphocyte clones reactive in primed lymphocyte typing and cytotoxicity , 1979, Nature.

[331]  D. Charmot,et al.  The in vitro cellular response of human lymphocytes totrinitrophenylated autologous cells: HLA‐D restrictionof proliferation but apparent absence of HLArestriction of cytolysis , 1979, European journal of immunology.

[332]  M. Julius,et al.  Antigen‐specific stimulation and trans‐stimulation of T cells in long‐term culture , 1979, European journal of immunology.

[333]  A. Silva,et al.  Human T cell growth factor. I. Optimal conditions for its production. , 1979, Journal of immunology.

[334]  F. Bach,et al.  Continuous culture of T cells cytotoxic for autologous human leukaemia cells , 1979, Nature.

[335]  Z. Fuks,et al.  Allograft Tolerance after Total Lymphoid Irradiation (TLI) , 1979, Immunological reviews.

[336]  J. Mulé,et al.  Selective localization of radiolabeled immune lymphocytes into syngeneic tumors. , 1979, Journal of immunology.

[337]  P. Greenberg,et al.  Suppression of the in vitro secondary response to syngeneic tumor and of in vivo tumor therapy with immune cells by culture-induced suppressor cells. , 1979, Journal of immunology.

[338]  D. W. Weiss,et al.  In vitro induction of cytotoxic effector cells against human neoplasms. I. Sensitization conditions and effect of cryopreservation on the induction and expression of cytotoxic responses to allogeneic leukemia cells. , 1979, Journal of immunological methods.

[339]  M. Potter.  Human Lymphocyte Differentiation: Its Application to Cancer , 1979, British Journal of Cancer.

[340]  Ryser Je,et al.  Limiting dilution analysis of alloantigen-reactive T lymphocytes. III. Effect of priming on precursor frequencies. , 1979 .

[341]  R. Jamasbi,et al.  Increase in immunogenicity with concomitant loss of tumorigenicity of respiratory tract carcinomas during in vitro culture. , 1979, Cancer research.

[342]  E. Borden,et al.  Activation of human natural killer cells cytotoxic for human leukemia cells by purified interferon. , 1979, Journal of immunology.

[343]  R. Herberman,et al.  The suppression of mitogen- and alloantigen-stimulated peripheral blood lymphocytes by cultured human T lymphocytes. , 1979, Journal of immunology.

[344]  T. Taniyama,et al.  Requirement of histocompatible macrophages for the induction of a secondary cytotoxic response to syngeneic tumor cells in vitro. , 1979, Journal of immunology.

[345]  E. Klein,et al.  Human tumor-lymphocyte interaction in vitro. VI. Specificity of primary and secondary autologous lymphocyte-mediated cytotoxicity. , 1979, Journal of the National Cancer Institute.

[346]  C. Henney,et al.  The differentiation of cytotoxic T cells in vitro. I. Amplifying factor(s) in the primary response is Lyt 1 + cell dependent. , 1979, Journal of immunology.

[347]  K. Tomonari,et al.  Induction of autoreactive cells by the preculture of human peripheral blood mononuclear cells with the autologous fresh plasma. , 1979, Journal of immunology.

[348]  L. Gooding.  Antibody blockade of lysis by T lymphocyte effectors generated against syngeneic SV40 transformed cells. , 1979, Journal of immunology.

[349]  R. Kurth,et al.  Cell-surface antigens induced by RNA tumour viruses , 1979, Nature.

[350]  D. Solter,et al.  Genetic control of the cytotoxic T cell response to SV40 tumor-associated specific antigen. , 1979, Journal of immunology.

[351]  D. Naor,et al.  Immune responses to weakly immunogenic virally induced tumors. V. Short in vitro cultivation of YAC changes its antigenic properties. , 1979, Cellular immunology.

[352]  I. Weissman,et al.  Moloney virus-induced cell surface antigens and histocompatibility antigens are located on distinct molecules. , 1979, Journal of immunology.

[353]  Ryser Je,et al.  Limiting Dilution Analysis of Alloantigen-Reactive T Lymphocytes I. Comparison of Precursor Frequencies for Proliferative and Cytolytic Responses , 1979 .

[354]  E. Appella,et al.  Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[355]  I. Bernstein,et al.  Cell‐mediated reactivity to antigens shared by moloney‐virus‐induced lymphomas (LSTRA) and certain 3‐methylcholanthrene‐induced mouse sarcomas , 1979, International journal of cancer.

[356]  R. Kiessling,et al.  An Analysis of the Murine NK Cell as to Structure, Function and Biological Relevance , 1979, Immunological reviews.

[357]  A. Senik,et al.  Association between H-2 and vaccinia virus-induced antigens on the surface of infected cells. , 1979, Journal of immunology.

[358]  G. Klein,et al.  Induction of tumor cell rejection in the low responsive YAC-lymphoma strain A host combination by immunization with somatic cell hybrids. , 1979, European journal of cancer.

[359]  H. Wigzell,et al.  Long term growth in vitro of human T cell blasts with maintenance of specificity and function. , 1979, Journal of immunology.

[360]  D. Talmage,et al.  Enhancement of the primary cytotoxic response to membrane by a lymphokine costimulator. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[361]  J. Woodward,et al.  Cell-mediated immune response to syngeneic UV-induced tumors. III. Requirement for an Ia+ macrophage in the in vitro differentiation of cytotoxic T lymphocytes. , 1979, Journal of immunology.

[362]  D. Naor,et al.  Immune responses to weakly immunogenic virally induced tumors. III. Genetically unrestricted cytolysis of allogeneic tumor target cells. , 1979, Journal of immunology.

[363]  W. Weigle,et al.  Nonspecific activation of murine lymphocytes. V. Role of cellular collaboration between T and B lymphocytes in the proliferative and polyclonal response to 2-mercaptoethanol. , 1979, Journal of immunology.

[364]  T. Igarashi,et al.  Studies of the mechanisms for the induction of in vivo tumor immunity. III. Recruitment of host helper cells by donor T cells in adoptive transfer of cell-mediated immunity. , 1979, Journal of immunology.

[365]  J. Ortaldo,et al.  Cytotoxicity by cultured human lymphocytes: characteristics of effector cells and specificity of cytotoxicity. , 1979, Journal of immunology.

[366]  T. Igarashi,et al.  Studies of the mechanisms for the induction of in vivo tumor immunity. IV. Enhancement of the in vitro generation of secondary cell-mediated cytotoxic response by normal peritoneal macrophages and their culture supernatants. , 1979, Journal of immunology.

[367]  D. Meruelo,et al.  A role for elevated H-2 antigen expression in resistance to neoplasia caused by radiation-induced leukemia virus. Enhancement of effective tumor surveillance by killer lymphocytes , 1979, The Journal of experimental medicine.

[368]  C. Riccardi,et al.  Natural Killer Cells: Characteristics and Regulation of Activity , 1979, Immunological reviews.

[369]  E. Kedar,et al.  In vitro induction of cell-mediated immunity to murine leukemia cells. VII. Methods for augmenting the induction and expression of cytotoxic response in vitro to syngeneic tumors. , 1979, Journal of immunological methods.

[370]  E. Kedar,et al.  Further characterization of suppressor lymphocytes induced by fetal calf serum in murine lymphoid cell cultures: comparison with in vitro-generated cytotoxic lymphocytes. , 1979, Cellular immunology.

[371]  J. Roder,et al.  Target-effector interaction in the natural killer cell system: isolation of target structures. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[372]  E. Appella,et al.  Biochemical characterization of alien H-2 antigens expressed on a methylcholanthrene-induced tumor. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[373]  D. Braun,et al.  Augmentation of antitumor cytotoxicity in MOPC-315 tumor bearer spleen cells by depletion of glass-adherent cells prior to in vitro activation. , 1979, Cancer research.

[374]  M. Glaser.  T-T cell synergy in the in vitro generation of secondary cell-mediated cytotoxicity against syngeneic SV-40 transformed cells. , 1979, Journal of immunology.

[375]  J. Russell,et al.  Cyclical changes in susceptibility of a myeloma tumor (LPC-1) to immune destruction. II. Periodic fluctuations during growth in normal and nude mice and in culture. , 1979, Journal of immunology.

[376]  D. Kilburn,et al.  Further characterization of thymic suppressor cells and a factor that suppress the generation of cells cytotoxic for a syngeneic tumor in DBA/2 mice. , 1979, Journal of immunology.

[377]  Glaser,et al.  Regulation of specific cell-mediated cytotoxic response against SV40- induced tumor associated antigens by depletion of suppressor T cells with cyclophosphamide in mice , 1979, The Journal of experimental medicine.

[378]  J. Russell,et al.  Tumor antigens as inappropriately expressed normal alloantigens. , 1979, Journal of immunology.

[379]  S. Segal,et al.  Differences in cell surface antigens of tumor metastases and those of the local tumor. , 1979, Journal of the National Cancer Institute.

[380]  J. Finke,et al.  Soluble helper factor(s) participates in the generation of cell mediated cytotoxicity directed against syngeneic tumor cells. , 1979, Journal of immunology.

[381]  J. Russell,et al.  Cyclical changes in susceptibility of a myeloma tumor (LPC-1) to immune destruction. I. Changes in reactivity with cytotoxic T lymphocytes and anti-H-2d sera. , 1979, Journal of immunology.

[382]  J. Ryser,et al.  Cell‐mediated immunity to antigens associated with murine sarcoma virus‐induced tumors: augmentation of cytolytic T lymphocyte activity by successive specific and nonspecific stimulation in vitro , 1979, European journal of immunology.

[383]  V. Schirrmacher,et al.  Tumor metastases and cell‐mediated immunity in a model system in DBA/2 mice.: Iv. Antigenic differences between a metastasizing variant and the parental tumor line revealed by cytotoxic T lymphocytes , 1979, International journal of cancer.

[384]  J. Klein.  The major histocompatibility complex of the mouse. , 1979, Science.

[385]  H. Kaplan,et al.  In vitro sensitization of human lymphocytes against histiocytic lymphoma cell lines. III. The activity of culture-induced suppressor cells. , 1979, Journal of immunology.

[386]  C. Feighery,et al.  HLA-D region-associated determinants serve as targets for human cell- mediated lysis , 1979, The Journal of experimental medicine.

[387]  J. Ihle,et al.  Antigenic specificities of the cellular immune response of C57BL/6 mice to the Moloney leukemia/sarcoma virus complex. , 1979, Journal of immunology.

[388]  J. Hamilton,et al.  Anti-self HLA may be clonally expressed , 1979, The Journal of experimental medicine.

[389]  A. Rubin,et al.  Selective suppression by adherent cells, prostaglandin, and cyclic AMP analogues of blastogenesis induced by different mitogens. , 1979, Journal of immunology.

[390]  J. Djeu,et al.  Augmentation of mouse natural killer cell activity by interferon and interferon inducers. , 1979, Journal of immunology.

[391]  V. Schirrmacher,et al.  Differences in the expression of histocompatibility antigens on mouse lymphocytes and tumor cells: immunochemical studies , 1979, European journal of immunology.

[392]  K. Smith,et al.  Monoclonal cytolytic T-cell lines , 1979, The Journal of experimental medicine.

[393]  J. Allison,et al.  Physical association of histocompatibility antigens and tumor-associated antigens on the surface of murine lymphoma cells. , 1979, Journal of immunology.

[394]  P. Golstein,et al.  Mouse T cell-mediated cytolysis specifically triggered by cytophilic xenogeneic serum determinants: a caveat for the interpretation of experiments done under "syngeneic" conditions. , 1978, Journal of immunology.

[395]  P. Greenberg,et al.  Tumor neutralization, immunotherapy, and chemoimmunotherapy of a Friend leukemia with cells secondarily sensitized in vitro: II. Comparison of cells cultured with and without tumor to noncultured immune cells. , 1978, Journal of immunology.

[396]  M. Röllinghoff,et al.  T-T-cell interactions during the vitro cytotoxic allograft responses. I. Soluble products from activated Lyl+ T cells trigger autonomously antigen-primed Ly23+ T cells to cell proliferation and cytolytic activity , 1978, The Journal of experimental medicine.

[397]  Kendall A. Smith,et al.  The effect of T cell growth factor on the generation of cytolytic T cells. , 1978, Journal of immunology.

[398]  I. Keshet,et al.  Association of Mouse Major Histocompatibility and Rauscher Murine Leukaemia Virus Envelope Glycoprotein Antigens on Leukaemia Cells and their Recognition by Syngeneic Virus‐Immune‐Cytotoxic T‐Lymphocytes , 1978, Scandinavian journal of immunology.

[399]  R. Weil.  Viral 'tumor antigens': A novel type of mammalian regulator protein. , 1978, Biochimica et biophysica acta.

[400]  O. Stutman,et al.  H–2 restriction and non-restriction of T-cell-mediated cytotoxicity against mouse mammary tumour targets , 1978, Nature.

[401]  O. Alaba,et al.  Secondary induction of cytotoxic T lymphocytes with solubilized syngeneic tumor cell plasma membranes , 1978, The Journal of experimental medicine.

[402]  L. Glimcher,et al.  The biologic significance of alloreactivity. The ontogeny of T-cell sets specific for alloantigens or modified self antigens , 1978, The Journal of experimental medicine.

[403]  J. Sosman,et al.  Enhancement of T cell cytotoxic responses by purified human fibroblast interferon. , 1978, Journal of immunology.

[404]  R. Simmons,et al.  CHARACTERIZATION OF SUPPRESSOR LYMPHOCYTES GENERATED IN VITRO , 1978, Transplantation.

[405]  P. A. Peterson,et al.  Molecular association between transplantation antigens and cell surface antigen in adenovirus-transformed cell line. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[406]  S. Rosenberg,et al.  In vitro growth of murine T cells. I. Production of factors necessary for T cell growth. , 1978, Journal of immunology.

[407]  M. Glaser.  Specific immune response against tumor-associated antigens of a syngeneic simian virus 40-induced sarcoma in mice. , 1978, Journal of the National Cancer Institute.

[408]  S. Rosenberg,et al.  In vitro growth of murine T cells. II. Growth of in vitro sensitized cells cytotoxic for alloantigens. , 1978, Journal of immunology.

[409]  D. Webb,et al.  Mitogen-induced changes in lymphocyte prostaglandin levels: a signal for the induction of suppressor cell activity. , 1978, Cellular immunology.

[410]  R. Burton,et al.  Immunogenicity of oncofetal antigens: a review. , 1978, Clinical immunology and immunopathology.

[411]  G. Nicolson,et al.  Specificity of arrest, survival, and growth of selected metastatic variant cell lines. , 1978, Cancer research.

[412]  S. Rosenberg,et al.  In vitro growth of cytotoxic human lymphocytes. I. Growth of cells sensitized in vitro to alloantigens. , 1978, Journal of immunology.

[413]  K. Smith,et al.  Long-term culture of human antigen-specific cytotoxic T-cell lines , 1978, The Journal of experimental medicine.

[414]  S. Segal,et al.  Specific cytotoxic lymphocytes against syngeneic tumors are generated in culture in the presence of syngeneic, but not xenogeneic, serum , 1978, International journal of cancer.

[415]  E. Klein,et al.  Restricted autologous lymphocytotoxicity in lung neoplasia. , 1978, British Journal of Cancer.

[416]  J. Haskill,et al.  In situ cytotoxic T cells in a methylcholanthrene-induced tumor. , 1978, Journal of immunology.

[417]  L. Chieco‐Bianchi,et al.  Secondary in vitro generation of cytolytic T-lymphocytes (CTL's) in the murine sarcoma virus system. Virus-specific CTL induction across the H-2 barrier. , 1978, Journal of the National Cancer Institute.

[418]  R. Rich,et al.  Suppression of cytotoxic lymphocyte responses in vitro by soluble products of alloantigen-activated spleen cells. , 1978, Journal of immunology.

[419]  D. Inbar,et al.  Loss of reactivity of a BALB/c myeloma tumor with allogeneic and syngeneic cytotoxic T lymphocytes , 1978, European journal of immunology.

[420]  A. Zander,et al.  AUTOLOGOUS BONE MARROW TRANSPLANTATION IN PATIENTS WITH ADULT ACUTE LEUKEMIA IN RELAPSE , 1978, Transplantation.

[421]  J. Levy,et al.  Cell‐mediated anti‐tumor response in the RL♂ 1 system I. T nature, H‐2 Dd involvement and antigenic specificity of the effector cells , 1978 .

[422]  F. Audibert,et al.  Biological activities of muramyl dipeptide, a synthetic glycopeptide analogous to bacterial immunoregulating agents. , 1978, Progress in allergy.

[423]  Y. Kaneko,et al.  Cytotoxic T lymphocytes to murine plasmacytoma cells in allogeneic and syngeneic mice: H-2 antigens are essential in the induction and effector stages of CTL. , 1978, Journal of immunology.

[424]  A. Treves.  In vitro Induction of Cell‐Mediated Immunity Against Tumor Cells by Antigen‐Fed Macrophages , 1978, Immunological reviews.

[425]  M. Nabholz,et al.  Colony formation of cytolytic T cells in semisolid medium , 1978, European journal of immunology.

[426]  F. Bach,et al.  Generation of cytotoxic T lymphocytes to autologous human leukaemia cells by sensitisation to pooled allogeneic normal cells , 1978, Nature.

[427]  R. Smith,et al.  Relationship of tumor‐specific transplantation antigens to the histocompatibility complex: Dissociation of in vitro alloantigen expression and in vivo alloimmunity from tumor‐specific transplantation antigen strength , 1978, International journal of cancer.

[428]  B. Schick,et al.  IS THE PRESENCE OF SEROLOGICALLY DEFINED TARGET CELL ANTIGENS SUFFICIENT FOR BINDING OF CYTOTOXIC T LYMPHOCYTES?1 , 1978, Transplantation.

[429]  J. Jaroszewski,et al.  Cytotoxicity of human peripheral lymphocytes in cell-mediated lympholysis; antibody-dependent cell-mediated lympholysis and natural cytotoxicity assays after mixed lymphocyte culture. , 1978, Journal of immunology.

[430]  R. Wiltrout,et al.  Isotope-release cytotoxicity assay with the use of indium-111: advantage over chromium-51 in long-term assays. , 1978, Journal of the National Cancer Institute.

[431]  T. Tada,et al.  Cellular interaction between cytotoxic and suppressor T cells against syngeneic tumors in the mouse. , 1978, Cellular immunology.

[432]  T. Waldmann,et al.  Suppressor cells in neoplastic disease. , 1978, Journal of the National Cancer Institute.

[433]  C. Brooks.  Studies on the microcytotoxicity test. III. Comparison of [75Se]selenomethionine with [3H]proline, Na2, 51CrO4 and [125I]iododeoxyuridine for pre-labelling target cells in long-term cytotoxicity tests. , 1978, Journal of immunological methods.

[434]  I. Hellstrom,et al.  An isotope-release assay and terminal-labeling assay for measuring cell-mediated allograft and tumor immunity to small numbers of adherent target cells. , 1978, Journal of immunological methods.

[435]  R. Prehn,et al.  ARE TUMOR‐ASSOCIATED TRANSPLANTATION ANTIGENS OF CHEMICALLY INDUCED SARCOMAS RELATED TO ALIEN HISTOCOMPATIBILITY ANTIGENS? , 1978, Transplantation.

[436]  L. Pilarski,et al.  Antigen‐specific suppression of cytotoxic T cell responses in mice. I. Suppressor T cells are not cytotoxic cells , 1978, European journal of immunology.

[437]  E. Kedar,et al.  Characteristics of suppressor cells induced by fetal bovine serum in murine lymphoid cell cultures. , 1978, Transplantation.

[438]  Kendall A. Smith,et al.  T cell growth factor: parameters of production and a quantitative microassay for activity. , 1978, Journal of immunology.

[439]  S. Targan,et al.  In vitro induction of cytotoxic effector cells with spontaneous killer cell specificity , 1978, The Journal of experimental medicine.

[440]  L. Law,et al.  T–T cell collaboration in rejection of a syngeneic SV40-induced sarcoma in mice , 1978, Nature.

[441]  I. Bernstein,et al.  Tumor-growth suppression in vivo: cooperation between immune lymphoid cells sensitized in vitro and nonimmune bone marrow cells. , 1978, Journal of immunology.

[442]  E. Klein,et al.  In vitro generation of cytotoxicity against autologous human tumour biopsy cells , 1978, International journal of cancer.

[443]  S. Singer,et al.  Participation of histocompatibility antigens in capping of molecularly independent cell surface components by their specific antibodies. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[444]  H. Kirchner.  Suppressor cells of immune reactivity in malignancy. , 1978, European journal of cancer.

[445]  H. Wigzell,et al.  cell surface glycoproteins of murine cytotoxic T lymphocytes. I. T 145, a new cell surface glycoprotein selectively expressed on Ly 1-2(+) cytotoxic T lymphocytes , 1978, Journal of Experimental Medicine.

[446]  G. Trinchieri,et al.  Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Identification of the anti-viral activity as interferon and characterization of the human effector lymphocyte subpopulation , 1978, The Journal of experimental medicine.

[447]  C. Fathman,et al.  Clones of alloreactive T cells , 1978, Nature.

[448]  S. Golub,et al.  Studies on cytotoxicity generated in human mixed lymphocyte cultures. I. Time course and target spectrum of several distinct concomitant cytotoxic activities. , 1978, Journal of immunology.

[449]  H. Lazarus,et al.  Two functionally distinct subpopulations of human T cells that collaborate in the generation of cytotoxic cells responsible for cell-mediated lympholysis. , 1978, Journal of immunology.

[450]  R. Dutton,et al.  Separation of helper and suppressor T lymphocytes. III. Positive and negative effects of mixed lymphocyte reaction-activated T cells. , 1978, Journal of immunology.

[451]  S. Segal,et al.  Generation of suppressor lymphocytes during sensitization in culture against a syngeneic tumor: affinity chromatography on insolubilized histamine. , 1978, Journal of immunology.

[452]  H. Mcdevitt,et al.  Suppression of the mixed lymphocyte reaction in man by a soluble T-cell factor. Specificity of the factor for both responder and stimulator , 1978, The Journal of experimental medicine.

[453]  M. Edidin,et al.  Inhibition of tumor growth mediated by lymphocytes sensitized in vitro to a syngeneic murine teratocarcinoma 402AX. , 1978, Journal of immunology.

[454]  G. Ada,et al.  A Dual Recognition Model for Cytotoxic T Cells Based on Thymic Selection of Precursors with Low Affinity for Self H‐2 Antigens , 1978, Scandinavian journal of immunology.

[455]  R. Oliver,et al.  Autologous leukemia-specific T-cell-mediated lymphocytotoxicity in patients with acute myelogenous leukemia , 1978, The Journal of experimental medicine.

[456]  Gale Rp,et al.  Autotransplantation for leukemia and solid tumors. , 1978 .

[457]  H. Rode,et al.  Regulation of the mixed leukocyte culture reaction by suppressor cells , 1978, European journal of immunology.

[458]  K. Shortman,et al.  Some requirements for a linear cell dose response in vitro assay for the T-cell progenitors of cytotoxic lymphocytes. , 1978, Journal of immunological methods.

[459]  B. Reitz,et al.  Transplantation tolerance in adult rats using total lymphoid irradiation: permanent survival of skin, heart, and marrow allografts , 1978, The Journal of experimental medicine.

[460]  A. Goldin,et al.  Adoptive immunochemotherapy of a transplantable AKR leukemia (K36) , 1978, International journal of cancer.

[461]  J. Ryser,et al.  Generation of cytolytic T lymphocytes in vitro. IX. induction of secondary CTL responses in primary long-term MLC by supernatants from secondary MLC. , 1978, Journal of immunology.

[462]  G. Snell.  T Cells, T Cell Recognition Structures, and the Major Histocompatibility Complex , 1978, Immunological reviews.

[463]  H. Macdonald.  Restimulation of cytolytic T-lymphocytes in long-term mixed leukocyte cultures. 1. Physical and proliferative characteristics of cytolytic T-lymphocytes restimulated at low cell density. , 1978, Cellular immunology.

[464]  C. Henney,et al.  BCG-induced suppressor cells. I. Demonstration of a macrophage-like suppressor cell that inhibits cytotoxic T cell generation in vitro. , 1978, Journal of immunology.

[465]  H. Rode,et al.  Blastogenic factor: its role in the mixed leukocyte culture reaction , 1978, European journal of immunology.

[466]  R. Zinkernagel,et al.  Cytotoxic T cells learn specificity for self H–2 during differentiation in the thymus , 1978, Nature.

[467]  E. Klein,et al.  Immune responses to weakly immunogenic virally induced tumors I. Overcoming low responsiveness by priming mice with a syngeneic in vitro tumor line or allogeneic cross‐reactive tumor , 1978, European journal of immunology.

[468]  E. Klein,et al.  Human tumour—lymphocyte interaction in vitro. V. Comparison of the reactivity of tumour‐infiltrating, blood and lymph‐node lymphocytes with autologous tumour cells , 1977, International Journal of Cancer.

[469]  R. Jamasbi,et al.  Increase in immunogenicity of a pulmonary squamous‐cell carcinoma, propagated in vitro , 1977, International journal of cancer.

[470]  A. McMichael,et al.  HLA restriction of cell-mediated lysis of influenza virus-infected human cells , 1977, Nature.

[471]  G. Klein,et al.  Immunization of mice with syngeneic Moloney lymphoma cells induces separate antibodies against virion envelope glycoprotein and virus- induced cell surface antigens , 1977, The Journal of experimental medicine.

[472]  B. Sharma.  In vitro immunization against human tumor cells with tumor cell fractions. , 1977, Cancer research.

[473]  M. Feldman,et al.  Hydrocortisone affects tumor growth by eliminating precursors of suppressor cells. , 1977, Journal of immunology.

[474]  W. Fridman,et al.  Human virus-infected target cells lacking HLA antigens resist specific T-lymphocyte cytolysis , 1977, Nature.

[475]  K. Blank,et al.  Evidence for an H–2/viral protein complex on the cell surface as the basis for the H–2 restriction of cytotoxicity , 1977, Nature.

[476]  Parish Cr.  Appearance of non-specific suppressor T cells during in vitro culture. , 1977 .

[477]  K. Lafferty,et al.  Activation of cytotoxic T cells by nonstimulating tumor cells and spleen cell factor(s). , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[478]  T. Rème,et al.  Exclusive involvement of H-2D(b) or H-2K(d) product in the interaction between T-killer lymphocytes and syngeneic H-2(b) or H-2(d) viral lymphomas , 1977, The Journal of experimental medicine.

[479]  R. Prehn.  Immunostimulation of the lymphodependent phase of neoplastic growth. , 1977, Journal of the National Cancer Institute.

[480]  H. Kaplan,et al.  In vitro sensitization of human lymphocytes against histiocytic lymphoma cell lines. II. Characterization of two different effector activities and of suppressor cells. , 1977, Journal of immunology.

[481]  L. Nadler,et al.  Regulatory mechanisms in cell-mediated immune responses. III. Antigen-specific and nonspecific suppressor activities generated during MLC. , 1977, Journal of immunology.

[482]  H. Kaplan,et al.  In vitro sensitization of human lymphocytes against histiocytic lymphoma cell lines. I. Primary sensitization of lymphocyte subpopulations. , 1977, Journal of immunology.

[483]  I. Fidler,et al.  Metastasis results from preexisting variant cells within a malignant tumor. , 1977, Science.

[484]  M. Cheever,et al.  Tumor neutralization, immunotherapy, and chemoimmmunotherapy of a Friend leukemia with cells secondarily sensitized in vitro. , 1977, Journal of immunology.

[485]  E. Thorsby,et al.  Activation of Human Suppressor Cells in Mixed Lymphocyte Cultures , 1977, Scandinavian journal of immunology.

[486]  D. Phillips,et al.  Reduction in cellular tumorigenicity after mycoplasma infection and elimination of mycoplasma from infected cultures by passage in nude mice. , 1977, Cancer research.

[487]  R. Herberman,et al.  Cytotoxicity against tumour-associated antigens not H–2 restricted , 1977, Nature.

[488]  Kendall A. Smith,et al.  Long term culture of tumour-specific cytotoxic T cells , 1977, Nature.

[489]  R. Burton,et al.  In vitro induction of tumor-specific immunity. VI: analysis of specificity of immune response by cellular competitive inhibition: limitations and advantages of the technique. , 1977, Journal of immunological methods.

[490]  R. Gallo,et al.  Functional and morphologic characterization of human T cells continuously grown in vitro. , 1977, Journal of immunology.

[491]  S. Ben‐Sasson,et al.  Enhancement of weak mixed lymphocyte-type reactions by hydrophilic polymers. , 1977, Journal of immunology.

[492]  R. A. Phillips,et al.  Quantitative Studies of the Activation of Cytotoxic Lymphocyte Precursor Cells , 1977, Immunological reviews.

[493]  W. Davidson.  Cellular Requirements for the Induction of Cytotoxic T Cells In vitro , 1977, Immunological reviews.

[494]  E. Kedar,et al.  In vitro induction of cell-mediated immunity to murine leukemia cells. II. cytotoxic activity in vitro and tumor-neutralizing capacity in vivo of anti-leukemia cytotoxic lymphocytes generated in macrocultures. , 1977, Journal of immunological methods.

[495]  C. Janeway,et al.  Environmental and Genetic Control of T Cell Activation In Vitro: A Study Using Isolated Alloantigen‐Activated T Cell Clones , 1977, Immunological reviews.

[496]  K. Chang,et al.  Properties of RBL-5 leukemia cells cultivated in vitro. , 1977, Journal of the National Cancer Institute.

[497]  Z. Pavelic,et al.  Increased primary cell-mediated immunity in culture subsequent to adriamycin or daunorubicin treatment of spleen donor mice. , 1977, Cancer research.

[498]  M. Brunda,et al.  In vitro immunisation against human tumour cells with bacterial extracts , 1977, Nature.

[499]  E. Thorsby,et al.  Cell mediated lympholysis: CML. a microplate technique requiring few target cells and employing a new method of supernatant collection. , 1977, Journal of immunological methods.

[500]  G. Klein,et al.  Immune surveillance against virus-induced tumors and nonrejectability of spontaneous tumors: contrasting consequences of host versus tumor evolution. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[501]  J. Remington,et al.  Studies on the regulation of lymphocyte reactivity by normal and activated macrophages. , 1977, Cellular immunology.

[502]  L. Law,et al.  Studies of H-2 restriction in cell-mediated cytotoxicity and transplantation immunity to Leukemia-associated antigens. , 1977, Journal of immunology.

[503]  R. Herberman,et al.  Surface antigens on transplantable tumor cell lines producing mouse type C viruses. , 1977, Journal of the National Cancer Institute.

[504]  G. Parmiani,et al.  MULTIPLE FOREIGN NON‐H‐2 DETERMINANTS ON THE SURFACE OF A CHEMICALLY‐INDUCED MURINE SARCOMA * , 1977, Journal of immunogenetics.

[505]  M. Lalande,et al.  Quantitative studies on the precursors of cytotoxic lymphocytes. VI. Second signal requirements of specifically activated precursors isolated 12 h after stimulation , 1980, The Journal of experimental medicine.

[506]  Bach Ml,et al.  Nature of target antigens in cell-mediated lympholysis. , 1977 .

[507]  F. Bach,et al.  Cellular immunogenetics and LD-CD collaboration. , 1977, Transplantation proceedings.

[508]  R. Burton,et al.  In vitro induction of tumor-specific immunity. III. Lack of requirement for H-2 compatibility in lysis of tumor targets by T cells activated in vitro to oncofetal and plasmacytoma antigens. , 1977, Journal of immunology.

[509]  J. Rice,et al.  H–2a-associated alloantigen expressed by several transplacentally-induced lung tumours of C3Hf mice , 1977, Nature.

[510]  G. Klein.  Tumor-associated antigens in H-2 hemizygous isoantigenic variants of a somatic cell hybrid, derived from the fusion of a 3-methylcholanthrene-induced sarcoma and a mammary carcinoma. , 1977, Journal of the National Cancer Institute.

[511]  F. Garrido,et al.  STUDIES ON H‐2 SPECIFICITIES ON MOUSE TUMOUR CELLS BY A NEW MICRORADIOASSAY * , 1977, Journal of immunogenetics.

[512]  A. Starzinski-Powitz,et al.  Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes , 1977, The Journal of experimental medicine.

[513]  S. Rosenberg,et al.  Normal adult murine cells in tissue culture express fetal antigens. , 1977, Transplantation.

[514]  B. Bonavida.  Concanavalin A-mediated activation of antigen-primed lymphocytes into secondary cytotoxic lymphocytes , 1977, The Journal of experimental medicine.

[515]  I. Bernstein,et al.  Passive transfer of systemic tumor immunity with cells generated in vitro by a secondary immune response to a syngeneic rat gross virus-induced lymphoma. , 1977, Journal of immunology.

[516]  N. Sinclair,et al.  Regulation of the immune response. XI-Cell-mediated feedback of an in vitro cell-mediated immune response. , 1976, Cellular immunology.

[517]  P. Schellekens,et al.  In Vitro Reactivity of Human Lymphocytes after Cryopreservation Using a Programmed Cooling Device , 1976, Scandinavian journal of immunology.

[518]  A. Nordin,et al.  Cell-mediated immune response in vitro. II. The mechanism(s) involved in the suppression of the development of cytotoxic lymphocytes. , 1976, Journal of immunology.

[519]  V. Jongeneel,et al.  Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus‐induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells , 1976, European journal of immunology.

[520]  B. Bonavida,et al.  Direct estimation of frequency of cytotoxic T lymphocytes by a modified plaque assay , 1976, Nature.

[521]  F. Bach,et al.  The Major Histocompatibility Complex — Genetics and Biology , 1976 .

[522]  R. Gorczynski.  Autoreactivity developing spontaneously in cultured mouse spleen cells. I. Evidence that cytotoxicity is directed against embryo-associated antigen. , 1976, Immunology.

[523]  S. Golub,et al.  Fetal calf serum-induced blastogenic and cytotoxic responses of human lymphocytes. , 1976, Cancer research.

[524]  L. Old,et al.  Ly phenotype of cytotoxic T cells for syngeneic tumor , 1976, The Journal of experimental medicine.

[525]  G. Edelman,et al.  Antiviral antibodies inhibit the lysis of tumour cells by anti-H–2 sera , 1976, Nature.

[526]  R. Cheung,et al.  Bacterial proteinaceous products (bacteriocins) as cytotoxic agents of neoplasia. , 1976, Cancer research.

[527]  B. Sharma.  In vitro lymphocyte immunization to cultured human tumor cells: parameters for generation of cytotoxic lymphocytes. , 1976, Journal of the National Cancer Institute.

[528]  T. Maki,et al.  Primary in vitro sensitization of murine lymphocytes against isogeneic and allogeneic cells transformed by simian virus 40. , 1976, Journal of immunology.

[529]  E. Kedar,et al.  In vitro induction of cell-mediated immunity to murine leukemia cells. I. Optimization of tissue culture conditions for the generation of cytotoxic lymphocytes. , 1976, Journal of immunological methods.

[530]  I. Cohen,et al.  T lymphocytes with promiscuous cytotoxicity , 1976, Nature.

[531]  R. Gallo,et al.  Selective in vitro growth of T lymphocytes from normal human bone marrows. , 1976, Science.

[532]  H. Ioachim.  The stromal reaction of tumors: an expression of immune surveillance. , 1976, Journal of the National Cancer Institute.

[533]  C. Buckley,et al.  ADOPTIVE TRANSFER AND SPECIFIC ACTIVE IMMUNIZATION OF PATIENTS WITH MALIGNANT MELANOMA * , 1976, Annals of the New York Academy of Sciences.

[534]  K. Hellström,et al.  CELL‐MEDIATED IMMUNITY TO MOUSE TUMORS: SOME RECENT FINDINGS * , 1976, Annals of the New York Academy of Sciences.

[535]  G. Edelman,et al.  Identification of the murine leukemia viral antigens detected on mouse cells by H‐2 alloantisera , 1976, European journal of immunology.

[536]  R. Bast,et al.  INDUCTION OF TUMOR IMMUNITY BY INTRATUMORAL CHEMOTHERAPY , 1976, Annals of the New York Academy of Sciences.

[537]  R. W. Baldwin,et al.  IMMUNOBIOLOGY OF RAT NEOPLASIA * , 1976, Annals of the New York Academy of Sciences.

[538]  M. Cheever,et al.  ADOPTIVE CHEMOIMMUNOTHERAPY OF CANCER IN ANIMALS: A REVIEW OF RESULTS, PRINCIPLES, AND PROBLEMS * , 1976, Annals of the New York Academy of Sciences.

[539]  J. Frenster.  PHYTOHEMAGGLUTININ‐ACTIVATED AUTOCHTHONOUS LYMPHOCYTES FOR SYSTEMIC IMMUNOTHERAPY OF HUMAN NEOPLASMS * , 1976, Annals of the New York Academy of Sciences.

[540]  L. Chieco‐Bianchi,et al.  Generation of cytotoxic cells in absence of blastogenesis by mouse leukemic cells in mixed cultures , 1976, European journal of immunology.

[541]  F. Bach,et al.  Generation of cytotoxic lymphocytes in vitro against autologous human leukaemia cells , 1976, Nature.

[542]  A. Matter.  PROTECTION AGAINST MURINE ASCITES TUMOURS BY LYMPHOID CELL POPULATIONS WITH T MEMORY OR CYTOTOXICITY , 1976, Transplantation.

[543]  N. Trainin,et al.  Separation of populations of sensitized lymphoid cells into fractions inhibiting and fractions enhancing syngeneic tumor growth in vivo. , 1976, Journal of immunology.

[544]  M. Hosokawa,et al.  Effect of combination treatment with cyclophosphamide and nonspecific passive immunization on a transplantable tumor in WKA rats. , 1976, Cancer research.

[545]  K. Hellström,et al.  Specific sensitization of lymphocytes to tumor antigens by Co‐cultivation with peritoneal cells exposed to such antigens , 1976, International journal of cancer.

[546]  G. Forni,et al.  Heterologous sera: a target for in vitro cell-mediated cytotoxicity. , 1976, Journal of immunology.

[547]  T. Aoki,et al.  Immunogenic and immunosuppressive components in soluble preparations from moloney murine leukemia virus‐induced tumor cells , 1976, International journal of cancer.

[548]  D. W. Weiss.  MER and other mycobacterial fractions in the immunotherapy of cancer. , 1976, The Medical clinics of North America.

[549]  I. Bernstein,et al.  Generation of cytotoxic lymphocytes in vitro: response of immune rat spleen cells to a syngeneic gross virus-induced lymphoma in mixed lymphocyte-tumor culture. , 1976, Journal of immunology.

[550]  A. Treves,et al.  Specific cytotoxicity in vitro of lymphocytes sensitized in culture against tumor cells. , 1976, Journal of the National Cancer Institute.

[551]  K. Clemetson,et al.  Water-soluble P-815 mastocytoma membrane antigens: separation of tumour-associated antigens from histocompatibility antigens. , 1976, Immunochemistry.

[552]  G. Trinchieri,et al.  Cell-mediated cytotoxicity to SV40-specific tumour-associated antigens , 1976, Nature.

[553]  R. Gupta,et al.  Human tumor cells grown in fetal calf serum and human serum: Influences on the tests for lymphocyte cytotoxicity, serum blocking and serum arming effects , 1976, International journal of cancer.

[554]  H. Macdonald,et al.  Increased cytolytic T lymphocyte activity induced by 2-mercaptoethanol in mixed leukocyte cultures: kinetics and possible mechanisms of action. , 1976, Journal of immunology.

[555]  M. Feldmann,et al.  SECONDARY CYTOTOXIC ALLOGRAFT RESPONSES IN VITRO: III. THE IMMUNOGENICITY OF ALLOGENEIC MEMBRANE FRAGMENTS , 1976, Transplantation.

[556]  A. Nordin,et al.  Cell-mediated immune response in vitro. I. The development of suppressor cells and cytotoxic lymphocytes in mixed lymphocyte cultures. , 1976, Journal of immunology.

[557]  H. Kirchner,et al.  Inhibition of cell-mediated cytotoxicity against tumor-associated antigens by suppressor cells from tumor-bearing mice. , 1976, Journal of the National Cancer Institute.

[558]  J. Plate.  Soluble factors substitute for T–T-cell collaboration in generation of T-killer lymphocytes , 1976, Nature.

[559]  G. Shellam,et al.  Studies on a gross‐virus‐induced lymphoma in the rat. III. Optimisation, specificity and applications of the in vitro immune response , 1976, International journal of cancer.

[560]  M. Greene,et al.  The genetic and cellular basis of regulation of the immune response to tumor antigens. , 1976, Contemporary topics in immunobiology.

[561]  J. Cerottini,et al.  Generation of cytotoxic T lymphocytes in vitro. VII. Suppressive effect of irradiated MLC cells on CTL response. , 1976, Journal of immunology.

[562]  H. Hewitt,et al.  A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin. , 1976, British Journal of Cancer.

[563]  M. Greene,et al.  Regualtion of the immune response to tumor antigens. I. Immunosuppressor cells in tumor-bearing hosts. , 1976, Journal of immunology.

[564]  R. Herberman,et al.  In vitro generation of secondary cell-mediated cytotoxic response against a syngeneic Gross virus-induced lymphoma in rats. , 1976, Journal of immunology.

[565]  F. Bach,et al.  Differential function of major histocompatibility complex antigens in T-lymphocyte activation , 1976, Nature.

[566]  G. Currie,et al.  Spontaneous shedding and antibody induced modulation of histocompatibility antigens on murine lymphomata: Correlation with metastic capacity. , 1976, British Journal of Cancer.

[567]  R. Hodes,et al.  In vitro generation of suppressor cell activity: suppression of in vitro induction if cell-mediated cytotoxicity. , 1976, Journal of immunology.

[568]  D. Campbell,et al.  Immunosuppressive activity of a subline of the mouse EL-4 lymphoma. Evidence for minute virus of mice causing the inhibition , 1976, The Journal of experimental medicine.

[569]  F. Bach,et al.  Recognitive specificity of human cytotoxic T lymphocytes. I. Antigen- specific inhibition of human cell-mediated lympholysis , 1975, The Journal of experimental medicine.

[570]  M. Röllinghoff,et al.  Induction of cytotoxic T lymphocytes against I-region-coded determinants: in vitro evidence for a third histocompatibility locus in the mouse , 1975, The Journal of experimental medicine.

[571]  G. Edelman,et al.  Functional interactions of viral and histocompatibility antigens at tumor cell surfaces. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[572]  M. Bevan.  The major histocompatibility complex determines susceptibility to cytotoxic T cells directed against minor histocompatibility antigens , 1975, The Journal of experimental medicine.

[573]  B. Bonavida,et al.  Studies on the induction and expression of T cell-mediated immunity. IV. Non-overlapping populations of alloimmune cytotoxic lymphocytes with specificity for tumor-associated antigens and transplantation antigens. , 1975, Journal of immunology.

[574]  L. Samelson,et al.  In vitro cell-mediated immune responses to the male specific(H-Y) antigen in mice , 1975, The Journal of experimental medicine.

[575]  Z. J. Lucas,et al.  Immune response to a syngeneic mammary adenocarcinoma. II. In vitro generation of cytotoxic lymphocytes. , 1975, Journal of immunology.

[576]  B. Benacerraf,et al.  Inhibition of T-lymphocyte-mediated tumor-specific lysis by alloantisera directed against the H-2 serological specificities of the tumor , 1975, The Journal of experimental medicine.

[577]  H. Macdonald,et al.  Generation of cytotoxic T lymphocytes in vitro. IV. Functional activation of memory cells in the absence of DNA synthesis , 1975, The Journal of experimental medicine.

[578]  C. Milstein,et al.  Continuous cultures of fused cells secreting antibody of predefined specificity , 1975, Nature.

[579]  R. Burton,et al.  In vitro induction of tumour-specific immunity. I. Development of optimal conditions for induction and assay of cytotoxic lymphocytes. , 1975, Journal of immunological methods.

[580]  J. Cerottini,et al.  Generation of cytotoxic T lymphocytes in vitro. V. Response of normal and immune spleen cells to subcellular alloantigens. , 1975, Journal of immunology.

[581]  R. Simes,et al.  Role of a non-committed accessory cell in the in vivo suppression of a syngeneic tumour by immune lymphocytes. , 1975, Immunology.

[582]  I. Cohen,et al.  Cell‐free media of mixed lymphocyte cultures augmenting sensitization in vitro of mouse T lymphocytes against allogeneic fibroblasts , 1975, European journal of immunology.

[583]  N. Trainin,et al.  Inhibition of syngeneic fibrosarcoma growth by lymphocytes sensitized on tumor‐cell monolayers in the presence of the thymic humoral factor , 1975, International journal of cancer.

[584]  A. Eggers,et al.  Suppressor cells in tumor-bearing mice capable of nonspecific blocking of in vitro immunization against transplant antigens. , 1975, Journal of immunology.

[585]  R Storb,et al.  Bone-marrow transplantation (first of two parts). , 1975, The New England journal of medicine.

[586]  C. Janeway,et al.  Functional heterogeneity among the T-derived lymphocytes of the mouse. IV. Nature of spontaneously induced suppressor cells. , 1975, Journal of immunology.

[587]  J. Cerottini,et al.  Primary and secondary in vitro generation of cytolytic T lymphocytes in the murine sarcoma virus system , 1975, European journal of immunology.

[588]  I. Cohen,et al.  Immunotherapy of lethal metastases by lymphocytes sensitized against tumor cells in vitro. , 1975, Journal of the National Cancer Institute.

[589]  I. Hellstrom,et al.  Specific stimulatory and cytotoxic effects of lymphocytes sensitized in vitro to either alloantigens or tumor antigens. , 1975, Journal of immunology.

[590]  D. Franks,et al.  Nonspecific cytotoxic effects of antigen-transformed lymphocytes. III. Relationship to specific cytotoxicity. , 1975, Cellular immunology.

[591]  M. Albala,et al.  Treatment of an established graft-versus-host reaction in AKR mice by adoptive immunotherapy. , 1975, Cancer research.

[592]  W. Enneking,et al.  Adoptive immunotherapy in primary osteosarcoma. An interim report. , 1975, The Journal of bone and joint surgery. American volume.

[593]  E. Klein,et al.  In vitro „education”︁ on autologous human sarcoma generates non‐specific killer cells , 1975, International journal of cancer.

[594]  E. Simpson,et al.  T-cell populations with different functions , 1975, Nature.

[595]  D. W. Weiss,et al.  Studies on the physiological manifestations of cell mediated cytotoxicity. II. Inhibition of (3-H)thymidine incorporation by plasmacytoma cells exposed in vitro to sensitized splenocytes. , 1975, Cellular immunology.

[596]  D. W. Weiss,et al.  Studies on the physiological manifestations of cell-mediated cytotoxicity. I. Early metabilic changes in mouse plasmacytoma cells exposed in vitro to sensitized allogeneic splenocytes. , 1975, Cellular immunology.

[597]  A. Goldin,et al.  Immunochemotherapy of transplantable Moloney leukemia with cyclophosphamide and allogeneic spleen lymphocytes and reversal of graft-versus-host disease with alloantiserum. , 1975, Cancer research.

[598]  D. W. Weiss,et al.  In vitro studies on cell-mediated cytotoxicity by means of a terminal labeling technique. , 1975, Cellular immunology.

[599]  F. Bach,et al.  Mouse Cell‐Mediated Lympholysis Assay in Serum‐Free and Mouse Serum‐Supplemented Media: Culture Conditions and Genetic Factors , 1975, Scandinavian journal of immunology.

[600]  I. Egorov,et al.  Private specificities of H-2K and H-2D loci as possible selective targets for effector lymphocytes in cell-mediated immunity , 1975, The Journal of experimental medicine.

[601]  K. Irie,et al.  Characteristics of heterologous membrane antigen on cultured human cells. , 1974, Journal of the National Cancer Institute.

[602]  R. Rich,et al.  Regulatory mechanisms in cell-mediated immune responses. IV. Expression of a receptor for mixed lymphocyte reaction suppressor factor on activated T lymphocytes , 1976, The Journal of experimental medicine.

[603]  S. Howell,et al.  Cell interactions in adoptive immune rejection of a syngeneic tumor , 1974, International journal of cancer.

[604]  R. Woutersen,et al.  Eradication of tumour cells by successive injections of allogeneic immune and hyperimmune peritoneal cells in a murine lymphoma system. , 1974, European journal of cancer.

[605]  R. Zinkernagel,et al.  Immunological surveillance against altered self components by sensitised T lymphocytes in lymphocytes choriomeningitis , 1974, Nature.

[606]  J. Klein,et al.  SEROLOGICAL DISTINCTION OF MUTANTS B6.C-H(z1) AND B6.M505 FROM STRAIN C57BL/6 , 1974, The Journal of experimental medicine.

[607]  A. Gazdar,et al.  Specificity of 5lCr-Release Cytotoxicity of Lymphocytes Immune to Murine Sarcoma Virus , 1974 .

[608]  G. Klein,et al.  Antibody-induced redistribution of normal and tumor associated surface antigens. , 1974, Experimental cell research.

[609]  D. Morton,et al.  Sensitisation of lymphocytes in vitro against human melanoma-associated antigens , 1974, Nature.

[610]  H. Robson MacDonald,et al.  GENERATION OF CYTOTOXIC T LYMPHOCYTES IN VITRO : I. RESPONSE OF NORMAL AND IMMUNE MOUSE SPLEEN CELLS IN MIXED LEUKOCYTE CULTURES , 1974 .

[611]  D. W. Weiss,et al.  Cellular immunity against Rous sarcomas of chickens. Preferential reactivity against autochthonous target cells as determined by lymphocyte adherence and cytotoxicity tests in vitro. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[612]  F. Scheiffarth.  CELL‐MEDIATED IMMUNE RESPONSE OF IN VITRO SENSITIZED LYMPHOCYTES TO ISOGENEIC METHYL‐CHOLANTHRENE‐INDUCED TUMOR CELL LINES , 1974, Transplantation.

[613]  H. Wigzell,et al.  Sensitization of Human Lymphocytes Against Autologous or Allogeneic Lymphoblastoid Cell Lines: Characteristics of the Reactive Cells , 1974, Scandinavian journal of immunology.

[614]  G. Shearer,et al.  Cell‐mediated cytotoxicity to trinitrophenyl‐modified syngeneic lymphocytes , 1974, European journal of immunology.

[615]  P. Neiman,et al.  Marrow transplants in aplastic anemia and leukemia. , 1974, Seminars in hematology.

[616]  D. Katz,et al.  ACTIVATION OF T AND B LYMPHOCYTES IN VITRO , 1974, The Journal of experimental medicine.

[617]  G. Klein,et al.  Sensitivity of different target cells to the killing action of peripheral lymphocytes stimulated by autologous lymphoblastoid cell lines , 1974, International journal of cancer.

[618]  P. Terasaki,et al.  Brief Communication: Immunization of Lymphocytes From Cancer Patients , 1974 .

[619]  C. Sherr,et al.  S‐tropic murine type‐C viruses: Frequency of isolation from continuous cell lines, leukemia virus preparations and normal spleens , 1974, International journal of cancer.

[620]  R. Gorczynski.  Immunity to murine sarcoma virus-inducted tumors. II. Suppression of T cell-mediated immunity by cells from progressor animals. , 1974, Journal of immunology.

[621]  M. Röllinghoff.  Secondary cytotoxic tumor immune response induced in vitro. , 1974, Journal of immunology.

[622]  M. Cohn,et al.  THE EFFECT OF 2-MERCAPTOETHANOL ON MURINE MIXED LYMPHOCYTE CULTURES , 1974, The Journal of experimental medicine.

[623]  I. Cohen,et al.  Autoimmune Encephalomyelitis: Activation of Thymus Lymphocytes against Syngeneic Brain Antigens in vitro , 1974, Science.

[624]  I. Cohen,et al.  STIMULATION OF RAT LYMPHOCYTE PROLIFERATION BY HYDROCORTISONE DURING THE INDUCTION OF CELL-MEDIATED IMMUNITY IN VITRO , 1974, Transplantation.

[625]  E. Krementz,et al.  Immunotherapy of malignant disease: The use of viable sensitized lymphocytes or transfer factor prepared from sensitized lymphocytes , 1974, Cancer.

[626]  I. Cohen,et al.  Recruitment of effector T lymphocytes against a tumor allograft by T lymphocytes sensitized in vitro. , 1973, Journal of the National Cancer Institute.

[627]  J. Schrader,et al.  Effect of azathioprine and cytosine arabinoside on humoral and cellular immunity in vitro. , 1973, Clinical and experimental immunology.

[628]  R. Lundak,et al.  Cellular immune response against tumor cells. I. In vitro immunization of allogeneic and syngeneic mouse spleen cell suspensions against DBA mastocytoma cells. , 1973, Cellular immunology.

[629]  M. Röllinghoff,et al.  In vitro induction of tumor specific immunity: requirements for T lymphocytes and tumor growth inhibition in vivo , 1973, European journal of immunology.

[630]  I. Cohen,et al.  In vitro cytotoxicity and in vivo tumor enhancement induced by mouse spleen cells autosensitized in vitro , 1973, International journal of cancer.

[631]  M. Röllinghoff,et al.  IN VITRO INDUCTION OF TUMOR-SPECIFIC IMMUNITY I. PARAMETERS OF ACTIVATION AND CYTOTOXIC REACTIVITY OF MOUSE LYMPHOID CELLS IMMUNIZED IN VITRO AGAINST SYNGENEIC AND ALLOGENEIC PLASMA CELL TUMORS , 1973 .

[632]  D. W. Weiss,et al.  Potentiation and modulation of the immune response of guinea pigs to poorly immunogenic protein-hapten conjugates by pretreatment with the MER fraction of attenuated tubercle bacilli. , 1973, Cellular immunology.

[633]  F. Bach,et al.  Lymphocyte reactivity to serologically undetected components of the major histocompatibility complex. , 1973, Nature: New biology.

[634]  A. Fefer.  Treatment of a Moloney lymphoma with cyclophosphamide and H-2-incompatible spleen cells. , 1973, Cancer research.

[635]  B. Rouse,et al.  Tumor immunity to murine plasma cell tumors. II. Essential role of T lymphocytes in immune response , 1973, European journal of immunology.

[636]  I. Bellany.  Controversy about MIRVs , 1973, Nature.

[637]  A. Rimm,et al.  Graft versus Leukemia: Quantification of Adoptive Immunotherapy in Murine Leukemia , 1973, Science.

[638]  G. Klein,et al.  Progressive loss of H-2 antigens with concomitant increase of cell-surface antigen(s) determined by Moloney leukemia virus in cultured murine lymphomas. , 1973, Journal of the National Cancer Institute.

[639]  B. Rouse,et al.  The in vivo activity of in vitro immunized mouse thymocytes. 3. Fate of in vitro immunized thymocytes. , 1972, Transplantation.

[640]  P. Terasaki,et al.  Cancer immunotherapy with HLA‐compatible thoracic duct lymphocyte transplantation. A preliminary report , 1972, Cancer.

[641]  Freedman Lr,et al.  In Vivo Studies of the Role of Cytotoxic T Cells in Tumor Allograft Immunity , 1972 .

[642]  H. Oettgen,et al.  Inhibition of established transplants of chemically induced sarcomas in syngeneic mice by lymphocytes from immunized donors , 1972, International journal of cancer.

[643]  M. Scott.  Biological effects of the adjuvant Corynebacterium parvum. I. Inhibition of PHA, mixed lymphocyte and GVH reactivity. , 1972, Cellular immunology.

[644]  R. Herberman,et al.  IN VITRO ACTIVATION OF CELLULAR IMMUNE RESPONSE TO GROSS VIRUS-INDUCED LYMPHOMA , 1972, The Journal of experimental medicine.

[645]  M. Feldmann,et al.  CELL-MEDIATED IMMUNE RESPONSE IN VITRO , 1972, The Journal of experimental medicine.

[646]  G. Klein,et al.  Cellular reactions against Burkitt lymphoma cells. III. Effector cell activity of leukocytes stimulated in vitro with autochthonous cultured lymphoma cells , 1972, International journal of cancer.

[647]  I. Gery,et al.  POTENTIATION OF THE T-LYMPHOCYTE RESPONSE TO MITOGENS , 1972, The Journal of experimental medicine.

[648]  H. Seigler,et al.  Non-specific and specific immunotherapy in patients with melanoma , 1972 .

[649]  A. Fefer,et al.  Studies of adoptive chemoimmunotherapy of a Friend virus-induced lymphoma. , 1972, Cancer research.

[650]  B. Rouse,et al.  In vivo activity of in vitro immunized lymphocytes. I. Tumor allograft rejection mediated by in vitro activated mouse thymocytes. , 1972, Journal of immunology.

[651]  H. Cantor,et al.  Synergy among lymphoid cells mediating the graft-versus-host response. 3. Evidence for interaction between two types of thymus-derived cells. , 1972, The Journal of experimental medicine.

[652]  E. Hersh,et al.  Local tumor immunotherapy with in vitro activated autochthonous lymphocytes , 1972 .

[653]  I. Gresser,et al.  Enhancement by interferon of the specific cytotoxicity of sensitized lymphocytes. , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[654]  R. E. Click,et al.  Immune responses in vitro. I. Culture conditions for antibody synthesis. , 1972, Cellular immunology.

[655]  W. Elkins.  Cellular Immunology and the Pathogenesis of Graft Versus Host Reactions (Part 1 of 3) , 1971 .

[656]  I. Cohen,et al.  AUTOSENSITIZATION IN VITRO , 1971, The Journal of experimental medicine.

[657]  I. Cohen,et al.  REJECTION OF TUMOR ALLOGRAFTS BY MOUSE SPLEEN CELLS SENSITIZED IN VITRO , 1971, The Journal of experimental medicine.

[658]  M. Boranić.  Time pattern of antileukemic effect of graft-versus-host reaction in mice. , 1971, Transplantation proceedings.

[659]  A. Goldin,et al.  Effect of combination treatment with cyclophosphamide and isogeneic or allogeneic spleen and bone marrow cells in leukemic (l1210) mice , 1971, International journal of cancer.

[660]  W. Jewell,et al.  Immunotherapy for the Patient with Cancer , 1971, Annals of surgery.

[661]  F. Bach,et al.  Cytotoxicity: Specificity after in vitro Sensitization , 1970, Science.

[662]  J. Wunderlich,et al.  Cell Mediated Immunity induced in Vitro , 1970, Nature.

[663]  G. Moore,et al.  Cancer immunity--hypothesis and clinical trial of lymphocytotherapy for malignant diseases. , 1970 .

[664]  N. Ling,et al.  Destruction of Lymphoid Cells by Activated Human Lymphocytes , 1970, Nature.

[665]  M. Schlesinger.  How Cells Acquire Antigens1 , 1970 .

[666]  R. Hodes,et al.  SPECIFIC CYTOTOXICITY OF H-2-INCOMPATIBLE MOUSE LYMPHOCYTES FOLLOWING MIXED CULTURE IN VITRO , 1970, Transplantation.

[667]  V. Defendi,et al.  Mixed Lymphocyte Cultures Produce Effector Cells: Model in vitro for Allograft Rejection , 1970, Science.

[668]  E. Klein,et al.  A MICROASSAY FOR CELL-MEDIATED IMMUNITY , 1970, Transplantation.

[669]  Mitchison Na.  Immunologic approach to cancer. , 1970 .

[670]  A. Fefer.  Immunotherapy and chemotherapy of Moloney sarcoma virus-induced tumors in mice. , 1969, Cancer research.

[671]  D. W. Weiss.  Immunologic parameters of host-tumor relationships: spontaneous mammary neoplasia of the inbred mouse as a model. , 1969, Cancer research.

[672]  D. W. Weiss.  IMMUNOLOGICAL PARAMETERS OF THE HOST‐PARASITE RELATIONSHIP IN NEOPLASIA * , 1969, Annals of the New York Academy of Sciences.

[673]  G. Moore,et al.  Immunotherapy of malignant disease. , 1969, Archives of surgery.

[674]  W. Ax,et al.  Graft reaction in tissue culture. II. Quantification of the lytic action on mouse fibroblasts by rat lymphocytes sensitized on mouse embryo monolayers. , 1969, Immunology.

[675]  E. Mihich.  Combined effects of chemotherapy and immunity against leukemia L1210 in DBA-2 mice. , 1969, Cancer research.

[676]  J. Vaage.  Nonvirus-associated antigens in virus-induced mouse mammary tumors. , 1968, Cancer research.

[677]  M. Boranić.  Transient Graft-Versus-Host Reaction in the Treatment of Leukemia in Mice , 1968 .

[678]  P. Alexander.  Immunotherapy of Cancer: Experiments with Primary Tumours and Syngeneic Tumour Grafts , 1968 .

[679]  J. Terblanche,et al.  Immunologically competent cells in the treatment of malignant disease. , 1968, Lancet.

[680]  H. Ginsburg.  Graft versus host reaction in tissue culture. I. Lysis of monolayers of embryo mouse cells from strains differing in the H-2 histocompatibility locus by rat lymphocytes sensitized in vitro. , 1968, Immunology.

[681]  B. Chapuis,et al.  Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. , 1968, Immunology.

[682]  P. Alexander.  Immunotherapy of leukemia: the use of different classes of immune lymphocytes. , 1967, Cancer research.

[683]  L. Sachs,et al.  Destruction of mouse and rat embryo cells in tissue culture by lymph node cells from unsensitized rats. , 1965, Journal of cellular physiology.

[684]  U. Essers,et al.  CANCER RESEARCH: SOME FORWARD STEPS. , 1965, Lancet.

[685]  M. Woodruff,et al.  Inhibitory Effect of Pre-Immunized CBA Spleen Cells on Transplants of A-strain Mouse Mammary Carcinoma in (CBA × A) F1 Hybrid Recipients , 1965, British Journal of Cancer.

[686]  E. Scanlon,et al.  Fatal homotransplanted melanoma. A case report , 1965 .

[687]  R. Weston,et al.  PATHOGENESIS OF COALMINER'S PNEUMOCONIOSIS. , 1965, Lancet.

[688]  E. Delorme,et al.  TREATMENT OF PRIMARY FIBROSARCOMA IN THE RAT WITH IMMUNE LYMPHOCYTES. , 1964, Lancet.

[689]  M. Woodruff,et al.  The Effect of Intraperitoneal Injection of Thoracic Duct Lymphocytes from Normal and Immunized Rats in Mice Inoculated with the Landschutz Ascites Tumour , 1963, British Journal of Cancer.

[690]  M. Woodruff,et al.  PRELIMINARY OBSERVATIONS ON TREATMENT OF ADVANCED CANCER BY INJECTION OF ALLOGENEIC SPLEEN CELLS. , 1963, Lancet.

[691]  M. Woodruff,et al.  The Effect of Rat Spleen Cells on Two Transplanted Mouse Tumours , 1963, British Journal of Cancer.

[692]  H. Winn,et al.  Immune mechanisms in homotransplantation. II. Quantitative assay of the immunologic activity of lymphoid cells stimulated by tumor homografts. , 1961, Journal of immunology.

[693]  E. Klein,et al.  Humoral and cellular factors in homograft and isograft immunity against sarcoma cells. , 1960, Cancer research.

[694]  J. Loutit,et al.  Treatment of Murine Leukaemia with X Rays and Homologous Bone Marrow , 1956, British medical journal.

[695]  H. Koprowski,et al.  Monoclonal antibody-defined human lung cell surface protein antigens. , 1982, Cancer research.

[696]  E. Mihich.  Immunological approaches to cancer therapeutics , 1982 .

[697]  M. Weksler,et al.  The autologous mixed-lymphocyte reaction. , 1981, Advances in immunology.

[698]  S. Swain,et al.  The Lyt phenotype of a long‐term allospecific T cell line. Both helper and killer activities to IA are mediated by Ly‐1 cells , 1981, European journal of immunology.

[699]  M. Epstein,et al.  Cytotoxic T cell recognition of Epstein‐Barr virus‐infected B cells. I. Specificity and HLA restriction of effector cells reactivated in vitro , 1981, European journal of immunology.

[700]  C. Rosenfeld,et al.  Suppressor cells in human cancer , 1981 .

[701]  U. Hämmerling,et al.  Generation of effector cells from T cell subsets III. Synergy between Lyt‐1 and Lyt‐123/23 lymphocytes in the generation of H‐2‐restricted and alloreactive cytotoxid T cells , 1981, European journal of immunology.

[702]  B. Benacerraf,et al.  Cellular interactions in the generation of cytolytic T lymphocyte responses Analysis of the helper T cell pathway , 1981, European journal of immunology.

[703]  E. Unanue.  The regulatory role of macrophages in antigenic stimulation. Part Two: symbiotic relationship between lymphocytes and macrophages. , 1981, Advances in immunology.

[704]  C. Lutz,et al.  Enumeration of alloreactive helper T lymphocytes which cooperate with cytolytic T lymphocytes , 1981, European journal of immunology.

[705]  B. Benacerraf,et al.  The role of T cell sets in the rejection of a methylcholanthrene-induced sarcoma (S1509a) in syngeneic mice. , 1981, The American journal of pathology.

[706]  J. Klein,et al.  Lyt phenotypes of primary cytotoxic T cells generated across the A and E region of the H‐2 complex , 1981, European journal of immunology.

[707]  K. Smith,et al.  T-cell growth factor and the culture of cloned functional T cells. , 1981, Advances in immunology.

[708]  W. Matthews,et al.  Cytotoxic cells suppress in vitro generation of cellular immunity by stimulator cell lysis. , 1981, Cellular immunology.

[709]  S. Rosenberg.  Serologic analysis of human cancer antigens , 1980 .

[710]  P. Puccetti,et al.  Immunologic reactivity of lymphoid cells in tumors. , 1980, Contemporary topics in immunobiology.

[711]  J. Brown,et al.  Monoclonal antibodies to tumor antigens. , 1980, Contemporary topics in immunobiology.

[712]  E. Klein,et al.  Separation and characteristics of tumor-infiltrating lymphocytes in man. , 1980, Contemporary topics in immunobiology.

[713]  I. Witz,et al.  A review of data, problems, and open questions pertaining to in situ tumor immunity. , 1980, Contemporary topics in immunobiology.

[714]  S. Rosenberg,et al.  In vitro growth of murine T cells. III. Method for separation of T cell growth factor (TCGF) from concanavalin A and biological activity of the resulting TCGF. , 1980, Journal of immunological methods.

[715]  S. von Kleist,et al.  Evidence for membrane-bound antibodies directed against antigens expressed on tumors. , 1980, Contemporary topics in immunobiology.

[716]  G. Dennert.  H-2-restricted T-cell-mediated cytotoxicity: rediscovering allo-H-2-reactivity? , 1980, Cellular immunology.

[717]  I. Witz,et al.  Tumor-localizing lymphocytotoxic antibodies. , 1980, Contemporary topics in immunobiology.

[718]  H. Ioachim,et al.  Correlations between tumor antigenicity, malignant potential, and local host immune response. , 1980, Contemporary topics in immunobiology.

[719]  J. Braatz,et al.  Removal of phytohemagglutinin from conditioned medium by affinity chromatography. , 1980, Journal of immunological methods.

[720]  K. Pfizenmaier,et al.  The role of the major histocompatibility gene complex in murine cytotoxic T cell responses. , 1980, Advances in cancer research.

[721]  D. Naor.  Suppressor cells: permitters and promoters of malignancy? , 1979, Advances in cancer research.

[722]  R. Arnon,et al.  Tumor-associated antigens and their specific immune response , 1979 .

[723]  R M Zinkernagel,et al.  MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness. , 1979, Advances in immunology.

[724]  D M Gersten,et al.  The biology of cancer invasion and metastasis. , 1978, Advances in cancer research.

[725]  R. Simmons,et al.  Differential cyclophosphamide sensitivity of suppressor and cytotoxic cell precursors. , 1978, Transplantation.

[726]  W. Terry,et al.  Immunotherapy of cancer : present status of trials in man , 1978 .

[727]  H. Hewitt.  The choice of animal tumors for experimental studies of cancer therapy. , 1978, Advances in cancer research.

[728]  R. Kiessling,et al.  Natural killer cells in the mouse: an alternative immune surveillance mechanism? , 1978, Contemporary topics in immunobiology.

[729]  R. Burton,et al.  In vitro induction and expression of T-cell immunity to tumor-associated antigens. , 1978, Contemporary topics in immunobiology.

[730]  H. Cantor,et al.  Regulation of the immune response by T-cell subclasses. , 1977, Contemporary topics in immunobiology.

[731]  E. Martz.  Mechanism of specific tumor-cell lysis by alloimmune T lymphocytes: resolution and characterization of discrete steps in the cellular interaction. , 1977, Contemporary topics in immunobiology.

[732]  H. Friedman,et al.  Immunosuppression and the role of suppressive factors in cancer. , 1977, Advances in cancer research.

[733]  G. Shearer,et al.  Significance of the major histocompatibility complex as assessed by T-cell-mediated lympholysis involving syngeneic stimulating cells. , 1977, Contemporary topics in immunobiology.

[734]  I. Witz,et al.  Tumor-bound immunoglobulins: in situ expressions of humoral immunity. , 1977, Advances in cancer research.

[735]  R. Zinkernagel,et al.  Major transplantation antigens, viruses, and specificity of surveillance T cells. , 1977, Contemporary topics in immunobiology.

[736]  R. W. Baldwin,et al.  Induction of tumor-immune responses and their interaction with the developing tumor. , 1977, Contemporary topics in molecular immunology.

[737]  N. Galili,et al.  Immune response to chemically modified antigens. , 1977, Progress in allergy.

[738]  J. Levy,et al.  The murine sarcoma virus-induced tumor: exception or general model in tumor immunology? , 1977, Advances in cancer research.

[739]  S. Rosenberg,et al.  Passive immunotherapy of cancer in animals and man. , 1977, Advances in cancer research.

[740]  J. Klein.  An attempt at an interpretation of the mouse H-2 complex. , 1976, Contemporary topics in immunobiology.

[741]  R. D. Stulting,et al.  Susceptibility of anti-H-2-capped target cells to humoral and T lymphocyte-mediated lysis. , 1976, Transplantation.

[742]  B. Bloom,et al.  In vitro methods in cell mediated and tumor immunity , 1976 .

[743]  Macdonald Hr,et al.  Generation of cytolytic T lymphocytes in vitro. , 1976, Contemporary topics in immunobiology.

[744]  J. Hansen,et al.  Human mixed-lymphocyte culture reaction: genetics, specificity, and biological implications. , 1976, Advances in immunology.

[745]  M. Tattersall,et al.  Perspectives in cancer research. Autologous Marrow Support and intensive chemotherapy in cancer patients. , 1976, European journal of cancer.

[746]  W. Clark,et al.  Effect of BUdR on proliferation and development of cytotoxicity in mixed leukocyte culture. , 1974, Cellular immunology.

[747]  J. Cerottini,et al.  Cell-mediated cytotoxicity, allograft rejection, and tumor immunity. , 1974, Advances in immunology.

[748]  R. Herberman.  Cell-mediated immunity to tumor cells. , 1974, Advances in cancer research.

[749]  P. Terasaki,et al.  In vitro immunization to cultured human tumor cells. , 1974, Cancer research.

[750]  G. Mathé,et al.  Bone Marrow Transplantation for Aplasias and Leukemias , 1974 .

[751]  I. Hellstrom,et al.  Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens. , 1974, Advances in immunology.

[752]  R. W. Baldwin.  Immunological aspects of chemical carcinogenesis. , 1973, Advances in cancer research.

[753]  S. Tevethia,et al.  Transplantation immunity to simian virus 40-transformed cells in tumor-bearing mice. II. Evidence for macrophage participation at the effector level of tumor cell rejection. , 1973, Journal of the National Cancer Institute.

[754]  G. Santos.  Application of Marrow Grafts in Human Disease: Its Problems and Potential , 1972 .

[755]  C. McPeak.  Intralymphatic therapy with immune lymphocytes , 1971, Cancer.

[756]  W. Elkins.  Cellular immunology and the pathogenesis of graft versus host reactions. , 1971, Progress in allergy.